Motif 595 (n=44)
Position-wise Probabilities
Download
uniprot | genes | site | source | protein | function |
---|---|---|---|---|---|
A0A075B6Q4 | None | S24 | ochoa | Protein LTV1 homolog | Essential for ribosome biogenesis. {ECO:0000256|ARBA:ARBA00043887}. |
A6NKT7 | RGPD3 | S1033 | ochoa | RanBP2-like and GRIP domain-containing protein 3 | None |
O14715 | RGPD8 | S1032 | ochoa | RANBP2-like and GRIP domain-containing protein 8 (Ran-binding protein 2-like 3) (RanBP2-like 3) (RanBP2L3) | None |
O15258 | RER1 | S95 | ochoa | Protein RER1 | Involved in the retrieval of endoplasmic reticulum membrane proteins from the early Golgi compartment. {ECO:0000250}. |
O60216 | RAD21 | S175 | ochoa|psp | Double-strand-break repair protein rad21 homolog (hHR21) (Nuclear matrix protein 1) (NXP-1) (SCC1 homolog) [Cleaved into: 64-kDa C-terminal product (64-kDa carboxy-terminal product) (65-kDa carboxy-terminal product)] | [Double-strand-break repair protein rad21 homolog]: As a member of the cohesin complex, involved in sister chromatid cohesion from the time of DNA replication in S phase to their segregation in mitosis, a function that is essential for proper chromosome segregation, post-replicative DNA repair, and the prevention of inappropriate recombination between repetitive regions (PubMed:11509732). The cohesin complex may also play a role in spindle pole assembly during mitosis (PubMed:11590136). In interphase, cohesins may function in the control of gene expression by binding to numerous sites within the genome (By similarity). May control RUNX1 gene expression (Probable). Binds to and represses APOB gene promoter (PubMed:25575569). May play a role in embryonic gut development, possibly through the regulation of enteric neuron development (By similarity). {ECO:0000250|UniProtKB:Q61550, ECO:0000250|UniProtKB:Q6TEL1, ECO:0000269|PubMed:11509732, ECO:0000269|PubMed:11590136, ECO:0000269|PubMed:25575569, ECO:0000305|PubMed:25575569}.; FUNCTION: [64-kDa C-terminal product]: May promote apoptosis. {ECO:0000269|PubMed:11875078, ECO:0000269|PubMed:12417729}. |
O75369 | FLNB | Y904 | ochoa | Filamin-B (FLN-B) (ABP-278) (ABP-280 homolog) (Actin-binding-like protein) (Beta-filamin) (Filamin homolog 1) (Fh1) (Filamin-3) (Thyroid autoantigen) (Truncated actin-binding protein) (Truncated ABP) | Connects cell membrane constituents to the actin cytoskeleton. May promote orthogonal branching of actin filaments and links actin filaments to membrane glycoproteins. Anchors various transmembrane proteins to the actin cytoskeleton. Interaction with FLNA may allow neuroblast migration from the ventricular zone into the cortical plate. Various interactions and localizations of isoforms affect myotube morphology and myogenesis. Isoform 6 accelerates muscle differentiation in vitro. |
O75962 | TRIO | S1818 | ochoa | Triple functional domain protein (EC 2.7.11.1) (PTPRF-interacting protein) | Guanine nucleotide exchange factor (GEF) for RHOA and RAC1 GTPases (PubMed:22155786, PubMed:27418539, PubMed:8643598). Involved in coordinating actin remodeling, which is necessary for cell migration and growth (PubMed:10341202, PubMed:22155786). Plays a key role in the regulation of neurite outgrowth and lamellipodia formation (PubMed:32109419). In developing hippocampal neurons, limits dendrite formation, without affecting the establishment of axon polarity. Once dendrites are formed, involved in the control of synaptic function by regulating the endocytosis of AMPA-selective glutamate receptors (AMPARs) at CA1 excitatory synapses (By similarity). May act as a regulator of adipogenesis (By similarity). {ECO:0000250|UniProtKB:F1M0Z1, ECO:0000269|PubMed:10341202, ECO:0000269|PubMed:22155786, ECO:0000269|PubMed:27418539, ECO:0000269|PubMed:32109419, ECO:0000269|PubMed:8643598}. |
P00533 | EGFR | S1081 | ochoa|psp | Epidermal growth factor receptor (EC 2.7.10.1) (Proto-oncogene c-ErbB-1) (Receptor tyrosine-protein kinase erbB-1) | Receptor tyrosine kinase binding ligands of the EGF family and activating several signaling cascades to convert extracellular cues into appropriate cellular responses (PubMed:10805725, PubMed:27153536, PubMed:2790960, PubMed:35538033). Known ligands include EGF, TGFA/TGF-alpha, AREG, epigen/EPGN, BTC/betacellulin, epiregulin/EREG and HBEGF/heparin-binding EGF (PubMed:12297049, PubMed:15611079, PubMed:17909029, PubMed:20837704, PubMed:27153536, PubMed:2790960, PubMed:7679104, PubMed:8144591, PubMed:9419975). Ligand binding triggers receptor homo- and/or heterodimerization and autophosphorylation on key cytoplasmic residues. The phosphorylated receptor recruits adapter proteins like GRB2 which in turn activates complex downstream signaling cascades. Activates at least 4 major downstream signaling cascades including the RAS-RAF-MEK-ERK, PI3 kinase-AKT, PLCgamma-PKC and STATs modules (PubMed:27153536). May also activate the NF-kappa-B signaling cascade (PubMed:11116146). Also directly phosphorylates other proteins like RGS16, activating its GTPase activity and probably coupling the EGF receptor signaling to the G protein-coupled receptor signaling (PubMed:11602604). Also phosphorylates MUC1 and increases its interaction with SRC and CTNNB1/beta-catenin (PubMed:11483589). Positively regulates cell migration via interaction with CCDC88A/GIV which retains EGFR at the cell membrane following ligand stimulation, promoting EGFR signaling which triggers cell migration (PubMed:20462955). Plays a role in enhancing learning and memory performance (By similarity). Plays a role in mammalian pain signaling (long-lasting hypersensitivity) (By similarity). {ECO:0000250|UniProtKB:Q01279, ECO:0000269|PubMed:10805725, ECO:0000269|PubMed:11116146, ECO:0000269|PubMed:11483589, ECO:0000269|PubMed:11602604, ECO:0000269|PubMed:12297049, ECO:0000269|PubMed:12297050, ECO:0000269|PubMed:12620237, ECO:0000269|PubMed:12873986, ECO:0000269|PubMed:15374980, ECO:0000269|PubMed:15590694, ECO:0000269|PubMed:15611079, ECO:0000269|PubMed:17115032, ECO:0000269|PubMed:17909029, ECO:0000269|PubMed:19560417, ECO:0000269|PubMed:20462955, ECO:0000269|PubMed:20837704, ECO:0000269|PubMed:21258366, ECO:0000269|PubMed:27153536, ECO:0000269|PubMed:2790960, ECO:0000269|PubMed:35538033, ECO:0000269|PubMed:7679104, ECO:0000269|PubMed:8144591, ECO:0000269|PubMed:9419975}.; FUNCTION: Isoform 2 may act as an antagonist of EGF action.; FUNCTION: (Microbial infection) Acts as a receptor for hepatitis C virus (HCV) in hepatocytes and facilitates its cell entry. Mediates HCV entry by promoting the formation of the CD81-CLDN1 receptor complexes that are essential for HCV entry and by enhancing membrane fusion of cells expressing HCV envelope glycoproteins. {ECO:0000269|PubMed:21516087}. |
P08651 | NFIC | Y299 | ochoa | Nuclear factor 1 C-type (NF1-C) (Nuclear factor 1/C) (CCAAT-box-binding transcription factor) (CTF) (Nuclear factor I/C) (NF-I/C) (NFI-C) (TGGCA-binding protein) | Recognizes and binds the palindromic sequence 5'-TTGGCNNNNNGCCAA-3' present in viral and cellular promoters and in the origin of replication of adenovirus type 2. These proteins are individually capable of activating transcription and replication. |
P0DJD0 | RGPD1 | S1017 | ochoa | RANBP2-like and GRIP domain-containing protein 1 (Ran-binding protein 2-like 6) (RanBP2-like 6) (RanBP2L6) | None |
P0DJD1 | RGPD2 | S1025 | ochoa | RANBP2-like and GRIP domain-containing protein 2 (Ran-binding protein 2-like 2) (RanBP2-like 2) (RanBP2L2) | None |
P10586 | PTPRF | S1305 | ochoa | Receptor-type tyrosine-protein phosphatase F (EC 3.1.3.48) (Leukocyte common antigen related) (LAR) | Possible cell adhesion receptor. It possesses an intrinsic protein tyrosine phosphatase activity (PTPase) and dephosphorylates EPHA2 regulating its activity.; FUNCTION: The first PTPase domain has enzymatic activity, while the second one seems to affect the substrate specificity of the first one. |
P39023 | RPL3 | S304 | ochoa | Large ribosomal subunit protein uL3 (60S ribosomal protein L3) (HIV-1 TAR RNA-binding protein B) (TARBP-B) | Component of the large ribosomal subunit (PubMed:12962325, PubMed:23636399, PubMed:32669547, PubMed:35674491). The ribosome is a large ribonucleoprotein complex responsible for the synthesis of proteins in the cell (PubMed:12962325, PubMed:23636399, PubMed:32669547). {ECO:0000269|PubMed:23636399, ECO:0000269|PubMed:32669547, ECO:0000305|PubMed:12962325}. |
P49792 | RANBP2 | S2008 | ochoa | E3 SUMO-protein ligase RanBP2 (EC 2.3.2.-) (358 kDa nucleoporin) (Nuclear pore complex protein Nup358) (Nucleoporin Nup358) (Ran-binding protein 2) (RanBP2) (p270) | E3 SUMO-protein ligase which facilitates SUMO1 and SUMO2 conjugation by UBE2I (PubMed:11792325, PubMed:12032081, PubMed:15378033, PubMed:15931224, PubMed:22194619). Involved in transport factor (Ran-GTP, karyopherin)-mediated protein import via the F-G repeat-containing domain which acts as a docking site for substrates (PubMed:7775481). Binds single-stranded RNA (in vitro) (PubMed:7775481). May bind DNA (PubMed:7775481). Component of the nuclear export pathway (PubMed:10078529). Specific docking site for the nuclear export factor exportin-1 (PubMed:10078529). Inhibits EIF4E-dependent mRNA export (PubMed:22902403). Sumoylates PML at 'Lys-490' which is essential for the proper assembly of PML-NB (PubMed:22155184). Recruits BICD2 to the nuclear envelope and cytoplasmic stacks of nuclear pore complex known as annulate lamellae during G2 phase of cell cycle (PubMed:20386726). Probable inactive PPIase with no peptidyl-prolyl cis-trans isomerase activity (PubMed:20676357, PubMed:23353830). {ECO:0000269|PubMed:11792325, ECO:0000269|PubMed:12032081, ECO:0000269|PubMed:15378033, ECO:0000269|PubMed:15931224, ECO:0000269|PubMed:20386726, ECO:0000269|PubMed:20676357, ECO:0000269|PubMed:22155184, ECO:0000269|PubMed:22194619, ECO:0000269|PubMed:22902403, ECO:0000269|PubMed:23353830, ECO:0000269|PubMed:7775481, ECO:0000303|PubMed:10078529}. |
P49810 | PSEN2 | S327 | psp | Presenilin-2 (PS-2) (EC 3.4.23.-) (AD3LP) (AD5) (E5-1) (STM-2) [Cleaved into: Presenilin-2 NTF subunit; Presenilin-2 CTF subunit] | Probable catalytic subunit of the gamma-secretase complex, an endoprotease complex that catalyzes the intramembrane cleavage of integral membrane proteins such as Notch receptors and APP (amyloid-beta precursor protein). Requires the other members of the gamma-secretase complex to have a protease activity. May play a role in intracellular signaling and gene expression or in linking chromatin to the nuclear membrane. May function in the cytoplasmic partitioning of proteins. The holoprotein functions as a calcium-leak channel that allows the passive movement of calcium from endoplasmic reticulum to cytosol and is involved in calcium homeostasis (PubMed:16959576). Is a regulator of mitochondrion-endoplasmic reticulum membrane tethering and modulates calcium ions shuttling between ER and mitochondria (PubMed:21285369). {ECO:0000269|PubMed:10497236, ECO:0000269|PubMed:10652302, ECO:0000269|PubMed:16959576, ECO:0000269|PubMed:21285369}. |
P60842 | EIF4A1 | S205 | ochoa | Eukaryotic initiation factor 4A-I (eIF-4A-I) (eIF4A-I) (EC 3.6.4.13) (ATP-dependent RNA helicase eIF4A-1) | ATP-dependent RNA helicase which is a subunit of the eIF4F complex involved in cap recognition and is required for mRNA binding to ribosome (PubMed:20156963). In the current model of translation initiation, eIF4A unwinds RNA secondary structures in the 5'-UTR of mRNAs which is necessary to allow efficient binding of the small ribosomal subunit, and subsequent scanning for the initiator codon. As a result, promotes cell proliferation and growth (PubMed:20156963). {ECO:0000269|PubMed:19153607, ECO:0000269|PubMed:19204291, ECO:0000269|PubMed:20156963}. |
Q00653 | NFKB2 | S23 | ochoa | Nuclear factor NF-kappa-B p100 subunit (DNA-binding factor KBF2) (H2TF1) (Lymphocyte translocation chromosome 10 protein) (Nuclear factor of kappa light polypeptide gene enhancer in B-cells 2) (Oncogene Lyt-10) (Lyt10) [Cleaved into: Nuclear factor NF-kappa-B p52 subunit] | NF-kappa-B is a pleiotropic transcription factor present in almost all cell types and is the endpoint of a series of signal transduction events that are initiated by a vast array of stimuli related to many biological processes such as inflammation, immunity, differentiation, cell growth, tumorigenesis and apoptosis. NF-kappa-B is a homo- or heterodimeric complex formed by the Rel-like domain-containing proteins RELA/p65, RELB, NFKB1/p105, NFKB1/p50, REL and NFKB2/p52. The dimers bind at kappa-B sites in the DNA of their target genes and the individual dimers have distinct preferences for different kappa-B sites that they can bind with distinguishable affinity and specificity. Different dimer combinations act as transcriptional activators or repressors, respectively. NF-kappa-B is controlled by various mechanisms of post-translational modification and subcellular compartmentalization as well as by interactions with other cofactors or corepressors. NF-kappa-B complexes are held in the cytoplasm in an inactive state complexed with members of the NF-kappa-B inhibitor (I-kappa-B) family. In a conventional activation pathway, I-kappa-B is phosphorylated by I-kappa-B kinases (IKKs) in response to different activators, subsequently degraded thus liberating the active NF-kappa-B complex which translocates to the nucleus. In a non-canonical activation pathway, the MAP3K14-activated CHUK/IKKA homodimer phosphorylates NFKB2/p100 associated with RelB, inducing its proteolytic processing to NFKB2/p52 and the formation of NF-kappa-B RelB-p52 complexes. The NF-kappa-B heterodimeric RelB-p52 complex is a transcriptional activator. The NF-kappa-B p52-p52 homodimer is a transcriptional repressor. NFKB2 appears to have dual functions such as cytoplasmic retention of attached NF-kappa-B proteins by p100 and generation of p52 by a cotranslational processing. The proteasome-mediated process ensures the production of both p52 and p100 and preserves their independent function. p52 binds to the kappa-B consensus sequence 5'-GGRNNYYCC-3', located in the enhancer region of genes involved in immune response and acute phase reactions. p52 and p100 are respectively the minor and major form; the processing of p100 being relatively poor. Isoform p49 is a subunit of the NF-kappa-B protein complex, which stimulates the HIV enhancer in synergy with p65. In concert with RELB, regulates the circadian clock by repressing the transcriptional activator activity of the CLOCK-BMAL1 heterodimer. {ECO:0000269|PubMed:7925301}. |
Q09666 | AHNAK | S4995 | ochoa | Neuroblast differentiation-associated protein AHNAK (Desmoyokin) | May be required for neuronal cell differentiation. |
Q13435 | SF3B2 | S362 | ochoa | Splicing factor 3B subunit 2 (Pre-mRNA-splicing factor SF3b 145 kDa subunit) (SF3b145) (Spliceosome-associated protein 145) (SAP 145) | Component of the 17S U2 SnRNP complex of the spliceosome, a large ribonucleoprotein complex that removes introns from transcribed pre-mRNAs (PubMed:12234937, PubMed:32494006, PubMed:34822310). The 17S U2 SnRNP complex (1) directly participates in early spliceosome assembly and (2) mediates recognition of the intron branch site during pre-mRNA splicing by promoting the selection of the pre-mRNA branch-site adenosine, the nucleophile for the first step of splicing (PubMed:12234937, PubMed:32494006, PubMed:34822310). Within the 17S U2 SnRNP complex, SF3B2 is part of the SF3B subcomplex, which is required for 'A' complex assembly formed by the stable binding of U2 snRNP to the branchpoint sequence in pre-mRNA (PubMed:12234937, PubMed:27720643). Sequence independent binding of SF3A and SF3B subcomplexes upstream of the branch site is essential, it may anchor U2 snRNP to the pre-mRNA (PubMed:12234937). May also be involved in the assembly of the 'E' complex (PubMed:10882114). Also acts as a component of the minor spliceosome, which is involved in the splicing of U12-type introns in pre-mRNAs (PubMed:15146077, PubMed:33509932). {ECO:0000269|PubMed:10882114, ECO:0000269|PubMed:12234937, ECO:0000269|PubMed:15146077, ECO:0000269|PubMed:27720643, ECO:0000269|PubMed:32494006, ECO:0000269|PubMed:33509932, ECO:0000269|PubMed:34822310}. |
Q5VUJ6 | LRCH2 | S364 | ochoa | Leucine-rich repeat and calponin homology domain-containing protein 2 | May play a role in the organization of the cytoskeleton. {ECO:0000250|UniProtKB:Q960C5, ECO:0000250|UniProtKB:Q96II8}. |
Q6UB99 | ANKRD11 | S857 | ochoa | Ankyrin repeat domain-containing protein 11 (Ankyrin repeat-containing cofactor 1) | Chromatin regulator which modulates histone acetylation and gene expression in neural precursor cells (By similarity). May recruit histone deacetylases (HDACs) to the p160 coactivators/nuclear receptor complex to inhibit ligand-dependent transactivation (PubMed:15184363). Has a role in proliferation and development of cortical neural precursors (PubMed:25556659). May also regulate bone homeostasis (By similarity). {ECO:0000250|UniProtKB:E9Q4F7, ECO:0000269|PubMed:15184363, ECO:0000269|PubMed:25556659}. |
Q6ZMG9 | CERS6 | S347 | psp | Ceramide synthase 6 (CerS6) (LAG1 longevity assurance homolog 6) (Sphingoid base N-palmitoyltransferase CERS6) (EC 2.3.1.291) | Ceramide synthase that catalyzes the transfer of the acyl chain from acyl-CoA to a sphingoid base, with high selectivity toward palmitoyl-CoA (hexadecanoyl-CoA; C16:0-CoA) (PubMed:17609214, PubMed:17977534, PubMed:23530041, PubMed:26887952, PubMed:31916624). Can use other acyl donors, but with less efficiency (By similarity). N-acylates sphinganine and sphingosine bases to form dihydroceramides and ceramides in de novo synthesis and salvage pathways, respectively (PubMed:17977534, PubMed:23530041, PubMed:26887952, PubMed:31916624). Ceramides generated by CERS6 play a role in inflammatory response (By similarity). Acts as a regulator of metabolism and hepatic lipid accumulation (By similarity). Under high fat diet, palmitoyl- (C16:0-) ceramides generated by CERS6 specifically bind the mitochondrial fission factor MFF, thereby promoting mitochondrial fragmentation and contributing to the development of obesity (By similarity). {ECO:0000250|UniProtKB:Q8C172, ECO:0000269|PubMed:17609214, ECO:0000269|PubMed:17977534, ECO:0000269|PubMed:23530041, ECO:0000269|PubMed:26887952, ECO:0000269|PubMed:31916624}. |
Q7KZ85 | SUPT6H | S1045 | ochoa | Transcription elongation factor SPT6 (hSPT6) (Histone chaperone suppressor of Ty6) (Tat-cotransactivator 2 protein) (Tat-CT2 protein) | Histone H3-H4 chaperone that plays a key role in the regulation of transcription elongation and mRNA processing. Enhances the transcription elongation by RNA polymerase II (RNAPII) and is also required for the efficient activation of transcriptional elongation by the HIV-1 nuclear transcriptional activator, Tat. Besides chaperoning histones in transcription, acts to transport and splice mRNA by forming a complex with IWS1 and the C-terminal domain (CTD) of the RNAPII subunit RPB1 (POLR2A). The SUPT6H:IWS1:CTD complex recruits mRNA export factors (ALYREF/THOC4, EXOSC10) as well as histone modifying enzymes (such as SETD2), to ensure proper mRNA splicing, efficient mRNA export and elongation-coupled H3K36 methylation, a signature chromatin mark of active transcription. SUPT6H via its association with SETD1A, regulates both class-switch recombination and somatic hypermutation through formation of H3K4me3 epigenetic marks on activation-induced cytidine deaminase (AICDA) target loci. Promotes the activation of the myogenic gene program by entailing erasure of the repressive H3K27me3 epigenetic mark through stabilization of the chromatin interaction of the H3K27 demethylase KDM6A. {ECO:0000269|PubMed:15060154, ECO:0000269|PubMed:17234882, ECO:0000269|PubMed:22316138, ECO:0000269|PubMed:23503590, ECO:0000269|PubMed:9514752}. |
Q7Z3J3 | RGPD4 | S1033 | ochoa | RanBP2-like and GRIP domain-containing protein 4 | None |
Q8IX21 | SLF2 | S710 | ochoa | SMC5-SMC6 complex localization factor protein 2 (Smc5/6 localization factor 1) | Plays a role in the DNA damage response (DDR) pathway by regulating postreplication repair of UV-damaged DNA and genomic stability maintenance (PubMed:25931565). The SLF1-SLF2 complex acts to link RAD18 with the SMC5-SMC6 complex at replication-coupled interstrand cross-links (ICL) and DNA double-strand breaks (DSBs) sites on chromatin during DNA repair in response to stalled replication forks (PubMed:25931565). Promotes the recruitment of the SMC5-SMC6 complex to DNA lesions (PubMed:25931565). Plays a role in SMC5-SMC6 complex recruitment for viral restriction. Forms a complex with SIMC1 and this complex is required to recruit SMC5-SMC6 complex to PML nuclear bodies and sites of viral replication (PubMed:36373674). {ECO:0000269|PubMed:25931565, ECO:0000269|PubMed:36373674}. |
Q8N157 | AHI1 | S328 | ochoa | Jouberin (Abelson helper integration site 1 protein homolog) (AHI-1) | Involved in vesicle trafficking and required for ciliogenesis, formation of primary non-motile cilium, and recruitment of RAB8A to the basal body of primary cilium. Component of the tectonic-like complex, a complex localized at the transition zone of primary cilia and acting as a barrier that prevents diffusion of transmembrane proteins between the cilia and plasma membranes. Involved in neuronal differentiation. As a positive modulator of classical Wnt signaling, may play a crucial role in ciliary signaling during cerebellum embryonic development (PubMed:21623382). {ECO:0000250|UniProtKB:Q8K3E5, ECO:0000269|PubMed:21623382}. |
Q92823 | NRCAM | S1251 | ochoa | Neuronal cell adhesion molecule (Nr-CAM) (Neuronal surface protein Bravo) (hBravo) (NgCAM-related cell adhesion molecule) (Ng-CAM-related) | Cell adhesion protein that is required for normal responses to cell-cell contacts in brain and in the peripheral nervous system. Plays a role in neurite outgrowth in response to contactin binding. Plays a role in mediating cell-cell contacts between Schwann cells and axons. Plays a role in the formation and maintenance of the nodes of Ranvier on myelinated axons. Nodes of Ranvier contain clustered sodium channels that are crucial for the saltatory propagation of action potentials along myelinated axons. During development, nodes of Ranvier are formed by the fusion of two heminodes. Required for normal clustering of sodium channels at heminodes; not required for the formation of mature nodes with normal sodium channel clusters. Required, together with GLDN, for maintaining NFASC and sodium channel clusters at mature nodes of Ranvier. {ECO:0000250|UniProtKB:Q810U4}. |
Q92993 | KAT5 | S199 | ochoa|psp | Histone acetyltransferase KAT5 (EC 2.3.1.48) (60 kDa Tat-interactive protein) (Tip60) (Histone acetyltransferase HTATIP) (HIV-1 Tat interactive protein) (Lysine acetyltransferase 5) (Protein 2-hydroxyisobutyryltransferase KAT5) (EC 2.3.1.-) (Protein acetyltransferase KAT5) (EC 2.3.1.-) (Protein crotonyltransferase KAT5) (EC 2.3.1.-) (Protein lactyltransferase KAT5) (EC 2.3.1.-) (cPLA(2)-interacting protein) | Catalytic subunit of the NuA4 histone acetyltransferase complex, a multiprotein complex involved in transcriptional activation of select genes principally by acetylation of nucleosomal histones H2A and H4 (PubMed:12776177, PubMed:14966270, PubMed:15042092, PubMed:15121871, PubMed:15310756, PubMed:16387653, PubMed:19909775, PubMed:25865756, PubMed:27153538, PubMed:29174981, PubMed:29335245, PubMed:32822602, PubMed:33076429). Histone acetylation alters nucleosome-DNA interactions and promotes interaction of the modified histones with other proteins which positively regulate transcription (PubMed:12776177, PubMed:14966270, PubMed:15042092, PubMed:15121871, PubMed:15310756). The NuA4 histone acetyltransferase complex is required for the activation of transcriptional programs associated with proto-oncogene mediated growth induction, tumor suppressor mediated growth arrest and replicative senescence, apoptosis, and DNA repair (PubMed:17709392, PubMed:19783983, PubMed:32832608). The NuA4 complex plays a direct role in repair of DNA double-strand breaks (DSBs) by promoting homologous recombination (HR): the complex inhibits TP53BP1 binding to chromatin via MBTD1, which recognizes and binds histone H4 trimethylated at 'Lys-20' (H4K20me), and KAT5 that catalyzes acetylation of 'Lys-15' of histone H2A (H2AK15ac), thereby blocking the ubiquitination mark required for TP53BP1 localization at DNA breaks (PubMed:27153538, PubMed:32832608). Also involved in DSB repair by mediating acetylation of 'Lys-5' of histone H2AX (H2AXK5ac), promoting NBN/NBS1 assembly at the sites of DNA damage (PubMed:17709392, PubMed:26438602). The NuA4 complex plays a key role in hematopoietic stem cell maintenance and is required to maintain acetylated H2A.Z/H2AZ1 at MYC target genes (By similarity). The NuA4 complex is also required for spermatid development by promoting acetylation of histones: histone hyperacetylation is required for histone replacement during the transition from round to elongating spermatids (By similarity). Component of a SWR1-like complex that specifically mediates the removal of histone H2A.Z/H2AZ1 from the nucleosome (PubMed:24463511). Also acetylates non-histone proteins, such as BMAL1, ATM, AURKB, CHKA, CGAS, ERCC4/XPF, LPIN1, TP53/p53, NDC80/HEC1, NR1D2, RAN, SOX4, FOXP3, SQSTM1, ULK1 and RUBCNL/Pacer (PubMed:16141325, PubMed:17189187, PubMed:17360565, PubMed:17996965, PubMed:24835996, PubMed:26829474, PubMed:29040603, PubMed:30409912, PubMed:30704899, PubMed:31857589, PubMed:32034146, PubMed:32817552, PubMed:34077757). Directly acetylates and activates ATM (PubMed:16141325). Promotes nucleotide excision repair (NER) by mediating acetylation of ERCC4/XPF, thereby promoting formation of the ERCC4-ERCC1 complex (PubMed:32034146). Relieves NR1D2-mediated inhibition of APOC3 expression by acetylating NR1D2 (PubMed:17996965). Acts as a regulator of regulatory T-cells (Treg) by catalyzing FOXP3 acetylation, thereby promoting FOXP3 transcriptional repressor activity (PubMed:17360565, PubMed:24835996). Involved in skeletal myoblast differentiation by mediating acetylation of SOX4 (PubMed:26291311). Catalyzes acetylation of APBB1/FE65, increasing its transcription activator activity (PubMed:33938178). Promotes transcription elongation during the activation phase of the circadian cycle by catalyzing acetylation of BMAL1, promoting elongation of circadian transcripts (By similarity). Together with GSK3 (GSK3A or GSK3B), acts as a regulator of autophagy: phosphorylated at Ser-86 by GSK3 under starvation conditions, leading to activate acetyltransferase activity and promote acetylation of key autophagy regulators, such as ULK1 and RUBCNL/Pacer (PubMed:30704899). Acts as a regulator of the cGAS-STING innate antiviral response by catalyzing acetylation the N-terminus of CGAS, thereby promoting CGAS DNA-binding and activation (PubMed:32817552). Also regulates lipid metabolism by mediating acetylation of CHKA or LPIN1 (PubMed:34077757). Promotes lipolysis of lipid droplets following glucose deprivation by mediating acetylation of isoform 1 of CHKA, thereby promoting monomerization of CHKA and its conversion into a tyrosine-protein kinase (PubMed:34077757). Acts as a regulator of fatty-acid-induced triacylglycerol synthesis by catalyzing acetylation of LPIN1, thereby promoting the synthesis of diacylglycerol (PubMed:29765047). In addition to protein acetyltransferase, can use different acyl-CoA substrates, such as (2E)-butenoyl-CoA (crotonyl-CoA), S-lactoyl-CoA (lactyl-CoA) and 2-hydroxyisobutanoyl-CoA (2-hydroxyisobutyryl-CoA), and is able to mediate protein crotonylation, lactylation and 2-hydroxyisobutyrylation, respectively (PubMed:29192674, PubMed:34608293, PubMed:38961290). Acts as a key regulator of chromosome segregation and kinetochore-microtubule attachment during mitosis by mediating acetylation or crotonylation of target proteins (PubMed:26829474, PubMed:29040603, PubMed:30409912, PubMed:34608293). Catalyzes acetylation of AURKB at kinetochores, increasing AURKB activity and promoting accurate chromosome segregation in mitosis (PubMed:26829474). Acetylates RAN during mitosis, promoting microtubule assembly at mitotic chromosomes (PubMed:29040603). Acetylates NDC80/HEC1 during mitosis, promoting robust kinetochore-microtubule attachment (PubMed:30409912). Catalyzes crotonylation of MAPRE1/EB1, thereby ensuring accurate spindle positioning in mitosis (PubMed:34608293). Catalyzes lactylation of NBN/NBS1 in response to DNA damage, thereby promoting DNA double-strand breaks (DSBs) via homologous recombination (HR) (PubMed:38961290). {ECO:0000250|UniProtKB:Q8CHK4, ECO:0000269|PubMed:12776177, ECO:0000269|PubMed:14966270, ECO:0000269|PubMed:15042092, ECO:0000269|PubMed:15121871, ECO:0000269|PubMed:15310756, ECO:0000269|PubMed:16141325, ECO:0000269|PubMed:16387653, ECO:0000269|PubMed:17189187, ECO:0000269|PubMed:17360565, ECO:0000269|PubMed:17709392, ECO:0000269|PubMed:17996965, ECO:0000269|PubMed:19783983, ECO:0000269|PubMed:19909775, ECO:0000269|PubMed:24463511, ECO:0000269|PubMed:24835996, ECO:0000269|PubMed:25865756, ECO:0000269|PubMed:26291311, ECO:0000269|PubMed:26438602, ECO:0000269|PubMed:26829474, ECO:0000269|PubMed:27153538, ECO:0000269|PubMed:29040603, ECO:0000269|PubMed:29174981, ECO:0000269|PubMed:29192674, ECO:0000269|PubMed:29335245, ECO:0000269|PubMed:29765047, ECO:0000269|PubMed:30409912, ECO:0000269|PubMed:30704899, ECO:0000269|PubMed:31857589, ECO:0000269|PubMed:32034146, ECO:0000269|PubMed:32817552, ECO:0000269|PubMed:32822602, ECO:0000269|PubMed:32832608, ECO:0000269|PubMed:33076429, ECO:0000269|PubMed:33938178, ECO:0000269|PubMed:34077757, ECO:0000269|PubMed:34608293, ECO:0000269|PubMed:38961290}.; FUNCTION: (Microbial infection) Catalyzes the acetylation of flavivirus NS3 protein to modulate their RNA-binding and -unwinding activities leading to facilitate viral replication. {ECO:0000269|PubMed:37478852}. |
Q92997 | DVL3 | S61 | psp | Segment polarity protein dishevelled homolog DVL-3 (Dishevelled-3) (DSH homolog 3) | Involved in the signal transduction pathway mediated by multiple Wnt genes. {ECO:0000250|UniProtKB:Q61062}. |
Q96DX4 | RSPRY1 | S55 | ochoa | RING finger and SPRY domain-containing protein 1 | None |
Q96GA3 | LTV1 | S200 | ochoa | Protein LTV1 homolog | Essential for ribosome biogenesis. {ECO:0000250|UniProtKB:Q5U3J8}. |
Q99666 | RGPD5 | S1032 | ochoa | RANBP2-like and GRIP domain-containing protein 5/6 (Ran-binding protein 2-like 1/2) (RanBP2-like 1/2) (RanBP2L1) (RanBP2L2) (Sperm membrane protein BS-63) | None |
Q9BVS4 | RIOK2 | S385 | ochoa | Serine/threonine-protein kinase RIO2 (EC 2.7.11.1) (RIO kinase 2) | Serine/threonine-protein kinase involved in the final steps of cytoplasmic maturation of the 40S ribosomal subunit. Involved in export of the 40S pre-ribosome particles (pre-40S) from the nucleus to the cytoplasm. Its kinase activity is required for the release of NOB1, PNO1 and LTV1 from the late pre-40S and the processing of 18S-E pre-rRNA to the mature 18S rRNA (PubMed:19564402). Regulates the timing of the metaphase-anaphase transition during mitotic progression, and its phosphorylation, most likely by PLK1, regulates this function (PubMed:21880710). {ECO:0000269|PubMed:16037817, ECO:0000269|PubMed:19564402, ECO:0000269|PubMed:21880710}. |
Q9H4G0 | EPB41L1 | S678 | ochoa | Band 4.1-like protein 1 (Erythrocyte membrane protein band 4.1-like 1) (Neuronal protein 4.1) (4.1N) | May function to confer stability and plasticity to neuronal membrane via multiple interactions, including the spectrin-actin-based cytoskeleton, integral membrane channels and membrane-associated guanylate kinases. |
Q9H7C9 | AAMDC | S46 | ochoa | Mth938 domain-containing protein (Adipogenesis associated Mth938 domain-containing protein) | May play a role in preadipocyte differentiation and adipogenesis. {ECO:0000250}. |
Q9HCK1 | ZDBF2 | S539 | ochoa | DBF4-type zinc finger-containing protein 2 | None |
Q9NR09 | BIRC6 | S473 | ochoa | Dual E2 ubiquitin-conjugating enzyme/E3 ubiquitin-protein ligase BIRC6 (EC 2.3.2.24) (BIR repeat-containing ubiquitin-conjugating enzyme) (BRUCE) (Baculoviral IAP repeat-containing protein 6) (Ubiquitin-conjugating BIR domain enzyme apollon) (APOLLON) | Anti-apoptotic protein known as inhibitor of apoptosis (IAP) which can regulate cell death by controlling caspases and by acting as an E3 ubiquitin-protein ligase (PubMed:14765125, PubMed:15200957, PubMed:18329369). Unlike most IAPs, does not contain a RING domain and it is not a RING-type E3 ligase (PubMed:15200957, PubMed:36758104, PubMed:36758105, PubMed:36758106). Instead acts as a dual E2/E3 enzyme that combines ubiquitin conjugating (E2) and ubiquitin ligase (E3) activities in a single polypeptide (PubMed:15200957, PubMed:36758104, PubMed:36758105, PubMed:36758106). Ubiquitination is mediated by a non-canonical E1 ubiquitin activating enzyme UBA6 (PubMed:36758104, PubMed:36758105, PubMed:36758106). Ubiquitinates CASP3, CASP7 and CASP9 and inhibits their caspase activity; also ubiquitinates their procaspases but to a weaker extent (PubMed:15200957, PubMed:36758104, PubMed:36758105, PubMed:36758106). Ubiquitinates pro-apoptotic factors DIABLO/SMAC and HTRA2 (PubMed:15200957, PubMed:36758104, PubMed:36758105, PubMed:36758106). DIABLO/SMAC antagonizes the caspase inhibition activity of BIRC6 by competing for the same binding sites as the caspases (PubMed:18329369, PubMed:36758106). Ubiquitinates the autophagy protein MAP1LC3B; this activity is also inhibited by DIABLO/SMAC (PubMed:36758105). Important regulator for the final stages of cytokinesis (PubMed:18329369). Crucial for normal vesicle targeting to the site of abscission, but also for the integrity of the midbody and the midbody ring, and its striking ubiquitin modification (PubMed:18329369). {ECO:0000269|PubMed:14765125, ECO:0000269|PubMed:15200957, ECO:0000269|PubMed:18329369, ECO:0000269|PubMed:36758104, ECO:0000269|PubMed:36758105, ECO:0000269|PubMed:36758106}. |
Q9NSK0 | KLC4 | S174 | ochoa | Kinesin light chain 4 (KLC 4) (Kinesin-like protein 8) | Kinesin is a microtubule-associated force-producing protein that may play a role in organelle transport. The light chain may function in coupling of cargo to the heavy chain or in the modulation of its ATPase activity (By similarity). {ECO:0000250}. |
Q9ULF5 | SLC39A10 | S556 | ochoa | Zinc transporter ZIP10 (Solute carrier family 39 member 10) (Zrt- and Irt-like protein 10) (ZIP-10) | Zinc-influx transporter (PubMed:17359283, PubMed:27274087, PubMed:30520657). When associated with SLC39A6, the heterodimer formed by SLC39A10 and SLC39A6 mediates cellular zinc uptake to trigger cells to undergo epithelial-to-mesenchymal transition (EMT) (PubMed:23186163). SLC39A10-SLC39A6 heterodimers play also an essentiel role in initiating mitosis by importing zinc into cells to initiate a pathway resulting in the onset of mitosis (PubMed:32797246). Plays an important for both mature B-cell maintenance and humoral immune responses (By similarity). When associated with SLC39A10, the heterodimer controls NCAM1 phosphorylation and integration into focal adhesion complexes during EMT (By similarity). {ECO:0000250|UniProtKB:Q6P5F6, ECO:0000269|PubMed:17359283, ECO:0000269|PubMed:23186163, ECO:0000269|PubMed:27274087, ECO:0000269|PubMed:30520657, ECO:0000269|PubMed:32797246}. |
Q9Y657 | SPIN1 | S196 | ochoa | Spindlin-1 (Ovarian cancer-related protein) (Spindlin1) | Chromatin reader that specifically recognizes and binds histone H3 both trimethylated at 'Lys-4' and 'Lys-9' (H3K4me3K9me3) and is involved in piRNA-mediated retrotransposon silencing during spermatogenesis (PubMed:33574238). Plays a key role in the initiation of the PIWIL4-piRNA pathway, a pathway that directs transposon DNA methylation and silencing in the male embryonic germ cells, by promoting recruitment of DNA methylation machinery to transposons: binds young, but not old, LINE1 transposons, which are specifically marked with H3K4me3K9me3, and promotes the recruitment of PIWIL4 and SPOCD1 to transposons, leading to piRNA-directed DNA methylation (By similarity). Also recognizes and binds histone H3 both trimethylated at 'Lys-4' and asymmetrically dimethylated at 'Arg-8' (H3K4me3 and H3R8me2a) and acts as an activator of Wnt signaling pathway downstream of PRMT2 (PubMed:22258766, PubMed:29061846). In case of cancer, promotes cell cancer proliferation via activation of the Wnt signaling pathway (PubMed:24589551). Overexpression induces metaphase arrest and chromosomal instability. Localizes to active rDNA loci and promotes the expression of rRNA genes (PubMed:21960006). May play a role in cell-cycle regulation during the transition from gamete to embryo (By similarity). Involved in oocyte meiotic resumption, a process that takes place before ovulation to resume meiosis of oocytes blocked in prophase I: may act by regulating maternal transcripts to control meiotic resumption (By similarity). {ECO:0000250|UniProtKB:Q61142, ECO:0000269|PubMed:21960006, ECO:0000269|PubMed:22258766, ECO:0000269|PubMed:24589551, ECO:0000269|PubMed:29061846, ECO:0000269|PubMed:33574238}. |
Q9Y6A5 | TACC3 | S190 | ochoa | Transforming acidic coiled-coil-containing protein 3 (ERIC-1) | Plays a role in the microtubule-dependent coupling of the nucleus and the centrosome. Involved in the processes that regulate centrosome-mediated interkinetic nuclear migration (INM) of neural progenitors (By similarity). Acts as a component of the TACC3/ch-TOG/clathrin complex proposed to contribute to stabilization of kinetochore fibers of the mitotic spindle by acting as inter-microtubule bridge. The TACC3/ch-TOG/clathrin complex is required for the maintenance of kinetochore fiber tension (PubMed:21297582, PubMed:23532825). May be involved in the control of cell growth and differentiation. May contribute to cancer (PubMed:14767476). {ECO:0000250|UniProtKB:Q9JJ11, ECO:0000269|PubMed:14767476, ECO:0000269|PubMed:21297582, ECO:0000269|PubMed:23532825}. |
Q15084 | PDIA6 | S169 | Sugiyama | Protein disulfide-isomerase A6 (EC 5.3.4.1) (Endoplasmic reticulum protein 5) (ER protein 5) (ERp5) (Protein disulfide isomerase P5) (Thioredoxin domain-containing protein 7) | May function as a chaperone that inhibits aggregation of misfolded proteins (PubMed:12204115). Negatively regulates the unfolded protein response (UPR) through binding to UPR sensors such as ERN1, which in turn inactivates ERN1 signaling (PubMed:24508390). May also regulate the UPR via the EIF2AK3 UPR sensor (PubMed:24508390). Plays a role in platelet aggregation and activation by agonists such as convulxin, collagen and thrombin (PubMed:15466936). {ECO:0000269|PubMed:12204115, ECO:0000269|PubMed:15466936, ECO:0000269|PubMed:24508390}. |
O00469 | PLOD2 | Y444 | Sugiyama | Procollagen-lysine,2-oxoglutarate 5-dioxygenase 2 (EC 1.14.11.4) (Lysyl hydroxylase 2) (LH2) | Forms hydroxylysine residues in -Xaa-Lys-Gly- sequences in collagens. These hydroxylysines serve as sites of attachment for carbohydrate units and are essential for the stability of the intermolecular collagen cross-links. {ECO:0000250|UniProtKB:P24802}. |
Q02809 | PLOD1 | Y434 | Sugiyama | Procollagen-lysine,2-oxoglutarate 5-dioxygenase 1 (EC 1.14.11.4) (Lysyl hydroxylase 1) (LH1) | Part of a complex composed of PLOD1, P3H3 and P3H4 that catalyzes hydroxylation of lysine residues in collagen alpha chains and is required for normal assembly and cross-linkling of collagen fibrils (By similarity). Forms hydroxylysine residues in -Xaa-Lys-Gly- sequences in collagens (PubMed:10686424, PubMed:15854030, PubMed:8621606). These hydroxylysines serve as sites of attachment for carbohydrate units and are essential for the stability of the intermolecular collagen cross-links (Probable). {ECO:0000250|UniProtKB:Q9R0E2, ECO:0000269|PubMed:10686424, ECO:0000269|PubMed:15854030, ECO:0000269|PubMed:8621606, ECO:0000305}. |
Download
reactome_id | name | p | -log10_p |
---|---|---|---|
R-HSA-9013507 | NOTCH3 Activation and Transmission of Signal to the Nucleus | 0.000086 | 4.067 |
R-HSA-1169408 | ISG15 antiviral mechanism | 0.001992 | 2.701 |
R-HSA-9012852 | Signaling by NOTCH3 | 0.000908 | 3.042 |
R-HSA-204998 | Cell death signalling via NRAGE, NRIF and NADE | 0.001859 | 2.731 |
R-HSA-8866910 | TFAP2 (AP-2) family regulates transcription of growth factors and their receptor... | 0.001843 | 2.734 |
R-HSA-422475 | Axon guidance | 0.001375 | 2.862 |
R-HSA-9675108 | Nervous system development | 0.001971 | 2.705 |
R-HSA-6791226 | Major pathway of rRNA processing in the nucleolus and cytosol | 0.002447 | 2.611 |
R-HSA-5368598 | Negative regulation of TCF-dependent signaling by DVL-interacting proteins | 0.014796 | 1.830 |
R-HSA-1251932 | PLCG1 events in ERBB2 signaling | 0.017729 | 1.751 |
R-HSA-447038 | NrCAM interactions | 0.020654 | 1.685 |
R-HSA-5638303 | Inhibition of Signaling by Overexpressed EGFR | 0.023570 | 1.628 |
R-HSA-5638302 | Signaling by Overexpressed Wild-Type EGFR in Cancer | 0.023570 | 1.628 |
R-HSA-5603029 | IkBA variant leads to EDA-ID | 0.023570 | 1.628 |
R-HSA-8857538 | PTK6 promotes HIF1A stabilization | 0.026478 | 1.577 |
R-HSA-2470946 | Cohesin Loading onto Chromatin | 0.029377 | 1.532 |
R-HSA-212718 | EGFR interacts with phospholipase C-gamma | 0.032268 | 1.491 |
R-HSA-201688 | WNT mediated activation of DVL | 0.035150 | 1.454 |
R-HSA-9700645 | ALK mutants bind TKIs | 0.035150 | 1.454 |
R-HSA-2468052 | Establishment of Sister Chromatid Cohesion | 0.038024 | 1.420 |
R-HSA-9820865 | Z-decay: degradation of maternal mRNAs by zygotically expressed factors | 0.046596 | 1.332 |
R-HSA-9927432 | Developmental Lineage of Mammary Gland Myoepithelial Cells | 0.004986 | 2.302 |
R-HSA-8847993 | ERBB2 Activates PTK6 Signaling | 0.052269 | 1.282 |
R-HSA-180336 | SHC1 events in EGFR signaling | 0.055093 | 1.259 |
R-HSA-6785631 | ERBB2 Regulates Cell Motility | 0.055093 | 1.259 |
R-HSA-9709603 | Impaired BRCA2 binding to PALB2 | 0.069090 | 1.161 |
R-HSA-9701193 | Defective homologous recombination repair (HRR) due to PALB2 loss of function | 0.071865 | 1.143 |
R-HSA-9701192 | Defective homologous recombination repair (HRR) due to BRCA1 loss of function | 0.071865 | 1.143 |
R-HSA-9704646 | Defective HDR through Homologous Recombination Repair (HRR) due to PALB2 loss of... | 0.071865 | 1.143 |
R-HSA-9704331 | Defective HDR through Homologous Recombination Repair (HRR) due to PALB2 loss of... | 0.071865 | 1.143 |
R-HSA-429947 | Deadenylation of mRNA | 0.085619 | 1.067 |
R-HSA-5693554 | Resolution of D-loop Structures through Synthesis-Dependent Strand Annealing (SD... | 0.088346 | 1.054 |
R-HSA-9709570 | Impaired BRCA2 binding to RAD51 | 0.099173 | 1.004 |
R-HSA-5619107 | Defective TPR may confer susceptibility towards thyroid papillary carcinoma (TPC... | 0.101860 | 0.992 |
R-HSA-1855196 | IP3 and IP4 transport between cytosol and nucleus | 0.104539 | 0.981 |
R-HSA-1855229 | IP6 and IP7 transport between cytosol and nucleus | 0.104539 | 0.981 |
R-HSA-1855170 | IPs transport between nucleus and cytosol | 0.109874 | 0.959 |
R-HSA-159227 | Transport of the SLBP independent Mature mRNA | 0.109874 | 0.959 |
R-HSA-72706 | GTP hydrolysis and joining of the 60S ribosomal subunit | 0.005574 | 2.254 |
R-HSA-159230 | Transport of the SLBP Dependant Mature mRNA | 0.112530 | 0.949 |
R-HSA-3301854 | Nuclear Pore Complex (NPC) Disassembly | 0.117819 | 0.929 |
R-HSA-159231 | Transport of Mature mRNA Derived from an Intronless Transcript | 0.128303 | 0.892 |
R-HSA-159234 | Transport of Mature mRNAs Derived from Intronless Transcripts | 0.130905 | 0.883 |
R-HSA-9954714 | PELO:HBS1L and ABCE1 dissociate a ribosome on a non-stop mRNA | 0.036025 | 1.443 |
R-HSA-975956 | Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC) | 0.036680 | 1.436 |
R-HSA-9954716 | ZNF598 and the Ribosome-associated Quality Trigger (RQT) complex dissociate a ri... | 0.039348 | 1.405 |
R-HSA-72165 | mRNA Splicing - Minor Pathway | 0.148907 | 0.827 |
R-HSA-192823 | Viral mRNA Translation | 0.045612 | 1.341 |
R-HSA-1799339 | SRP-dependent cotranslational protein targeting to membrane | 0.049240 | 1.308 |
R-HSA-1643713 | Signaling by EGFR in Cancer | 0.091064 | 1.041 |
R-HSA-1236382 | Constitutive Signaling by Ligand-Responsive EGFR Cancer Variants | 0.074632 | 1.127 |
R-HSA-5637815 | Signaling by Ligand-Responsive EGFR Variants in Cancer | 0.074632 | 1.127 |
R-HSA-5637812 | Signaling by EGFRvIII in Cancer | 0.063516 | 1.197 |
R-HSA-5637810 | Constitutive Signaling by EGFRvIII | 0.063516 | 1.197 |
R-HSA-9665348 | Signaling by ERBB2 ECD mutants | 0.066307 | 1.178 |
R-HSA-182971 | EGFR downregulation | 0.104539 | 0.981 |
R-HSA-927802 | Nonsense-Mediated Decay (NMD) | 0.052971 | 1.276 |
R-HSA-180292 | GAB1 signalosome | 0.066307 | 1.178 |
R-HSA-156902 | Peptide chain elongation | 0.034086 | 1.467 |
R-HSA-975957 | Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC) | 0.052971 | 1.276 |
R-HSA-9948299 | Ribosome-associated quality control | 0.078151 | 1.107 |
R-HSA-5607761 | Dectin-1 mediated noncanonical NF-kB signaling | 0.146358 | 0.835 |
R-HSA-9665686 | Signaling by ERBB2 TMD/JMD mutants | 0.085619 | 1.067 |
R-HSA-9664565 | Signaling by ERBB2 KD Mutants | 0.099173 | 1.004 |
R-HSA-9954709 | Ribosome Quality Control (RQC) complex extracts and degrades nascent peptide | 0.040027 | 1.398 |
R-HSA-179812 | GRB2 events in EGFR signaling | 0.046596 | 1.332 |
R-HSA-9664420 | Killing mechanisms | 0.057909 | 1.237 |
R-HSA-9673324 | WNT5:FZD7-mediated leishmania damping | 0.057909 | 1.237 |
R-HSA-1250196 | SHC1 events in ERBB2 signaling | 0.101860 | 0.992 |
R-HSA-5685938 | HDR through Single Strand Annealing (SSA) | 0.109874 | 0.959 |
R-HSA-156827 | L13a-mediated translational silencing of Ceruloplasmin expression | 0.005574 | 2.254 |
R-HSA-5676590 | NIK-->noncanonical NF-kB signaling | 0.133500 | 0.875 |
R-HSA-72613 | Eukaryotic Translation Initiation | 0.006941 | 2.159 |
R-HSA-5693537 | Resolution of D-Loop Structures | 0.112530 | 0.949 |
R-HSA-2500257 | Resolution of Sister Chromatid Cohesion | 0.061517 | 1.211 |
R-HSA-72737 | Cap-dependent Translation Initiation | 0.006941 | 2.159 |
R-HSA-72764 | Eukaryotic Translation Termination | 0.040027 | 1.398 |
R-HSA-5693568 | Resolution of D-loop Structures through Holliday Junction Intermediates | 0.109874 | 0.959 |
R-HSA-1227990 | Signaling by ERBB2 in Cancer | 0.101860 | 0.992 |
R-HSA-4641262 | Disassembly of the destruction complex and recruitment of AXIN to the membrane | 0.093775 | 1.028 |
R-HSA-9675136 | Diseases of DNA Double-Strand Break Repair | 0.115178 | 0.939 |
R-HSA-9017802 | Noncanonical activation of NOTCH3 | 0.023570 | 1.628 |
R-HSA-2179392 | EGFR Transactivation by Gastrin | 0.038024 | 1.420 |
R-HSA-68884 | Mitotic Telophase/Cytokinesis | 0.043747 | 1.359 |
R-HSA-1810476 | RIP-mediated NFkB activation via ZBP1 | 0.055093 | 1.259 |
R-HSA-1963640 | GRB2 events in ERBB2 signaling | 0.060716 | 1.217 |
R-HSA-73980 | RNA Polymerase III Transcription Termination | 0.066307 | 1.178 |
R-HSA-933542 | TRAF6 mediated NF-kB activation | 0.085619 | 1.067 |
R-HSA-9701190 | Defective homologous recombination repair (HRR) due to BRCA2 loss of function | 0.115178 | 0.939 |
R-HSA-180910 | Vpr-mediated nuclear import of PICs | 0.123076 | 0.910 |
R-HSA-72689 | Formation of a pool of free 40S subunits | 0.040027 | 1.398 |
R-HSA-168333 | NEP/NS2 Interacts with the Cellular Export Machinery | 0.146358 | 0.835 |
R-HSA-9609690 | HCMV Early Events | 0.134710 | 0.871 |
R-HSA-156842 | Eukaryotic Translation Elongation | 0.037340 | 1.428 |
R-HSA-1963642 | PI3K events in ERBB2 signaling | 0.063516 | 1.197 |
R-HSA-4641258 | Degradation of DVL | 0.123076 | 0.910 |
R-HSA-418885 | DCC mediated attractive signaling | 0.055093 | 1.259 |
R-HSA-170822 | Regulation of Glucokinase by Glucokinase Regulatory Protein | 0.112530 | 0.949 |
R-HSA-5693579 | Homologous DNA Pairing and Strand Exchange | 0.125693 | 0.901 |
R-HSA-68877 | Mitotic Prometaphase | 0.131694 | 0.880 |
R-HSA-2467813 | Separation of Sister Chromatids | 0.102529 | 0.989 |
R-HSA-9839383 | TGFBR3 PTM regulation | 0.032268 | 1.491 |
R-HSA-5693548 | Sensing of DNA Double Strand Breaks | 0.043747 | 1.359 |
R-HSA-388844 | Receptor-type tyrosine-protein phosphatases | 0.057909 | 1.237 |
R-HSA-881907 | Gastrin-CREB signalling pathway via PKC and MAPK | 0.069090 | 1.161 |
R-HSA-8863795 | Downregulation of ERBB2 signaling | 0.101860 | 0.992 |
R-HSA-180746 | Nuclear import of Rev protein | 0.115178 | 0.939 |
R-HSA-5693616 | Presynaptic phase of homologous DNA pairing and strand exchange | 0.117819 | 0.929 |
R-HSA-9820841 | M-decay: degradation of maternal mRNAs by maternally stored factors | 0.133500 | 0.875 |
R-HSA-2408557 | Selenocysteine synthesis | 0.044190 | 1.355 |
R-HSA-168273 | Influenza Viral RNA Transcription and Replication | 0.014969 | 1.825 |
R-HSA-445095 | Interaction between L1 and Ankyrins | 0.093775 | 1.028 |
R-HSA-399719 | Trafficking of AMPA receptors | 0.104539 | 0.981 |
R-HSA-9924644 | Developmental Lineages of the Mammary Gland | 0.023935 | 1.621 |
R-HSA-177243 | Interactions of Rev with host cellular proteins | 0.130905 | 0.883 |
R-HSA-176033 | Interactions of Vpr with host cellular proteins | 0.130905 | 0.883 |
R-HSA-168271 | Transport of Ribonucleoproteins into the Host Nucleus | 0.133500 | 0.875 |
R-HSA-9633012 | Response of EIF2AK4 (GCN2) to amino acid deficiency | 0.046329 | 1.334 |
R-HSA-201681 | TCF dependent signaling in response to WNT | 0.121763 | 0.914 |
R-HSA-3134963 | DEx/H-box helicases activate type I IFN and inflammatory cytokines production | 0.020654 | 1.685 |
R-HSA-448706 | Interleukin-1 processing | 0.035150 | 1.454 |
R-HSA-9013700 | NOTCH4 Activation and Transmission of Signal to the Nucleus | 0.035150 | 1.454 |
R-HSA-193692 | Regulated proteolysis of p75NTR | 0.035150 | 1.454 |
R-HSA-165054 | Rev-mediated nuclear export of HIV RNA | 0.125693 | 0.901 |
R-HSA-168274 | Export of Viral Ribonucleoproteins from Nucleus | 0.148907 | 0.827 |
R-HSA-1606322 | ZBP1(DAI) mediated induction of type I IFNs | 0.066307 | 1.178 |
R-HSA-442380 | Zinc influx into cells by the SLC39 gene family | 0.035150 | 1.454 |
R-HSA-77387 | Insulin receptor recycling | 0.096478 | 1.016 |
R-HSA-168276 | NS1 Mediated Effects on Host Pathways | 0.128303 | 0.892 |
R-HSA-9604323 | Negative regulation of NOTCH4 signaling | 0.130905 | 0.883 |
R-HSA-9734779 | Developmental Cell Lineages of the Integumentary System | 0.049978 | 1.301 |
R-HSA-5663202 | Diseases of signal transduction by growth factor receptors and second messengers | 0.075208 | 1.124 |
R-HSA-8953854 | Metabolism of RNA | 0.012970 | 1.887 |
R-HSA-2979096 | NOTCH2 Activation and Transmission of Signal to the Nucleus | 0.074632 | 1.127 |
R-HSA-6794362 | Protein-protein interactions at synapses | 0.031568 | 1.501 |
R-HSA-373752 | Netrin-1 signaling | 0.143801 | 0.842 |
R-HSA-9675135 | Diseases of DNA repair | 0.148907 | 0.827 |
R-HSA-447043 | Neurofascin interactions | 0.026478 | 1.577 |
R-HSA-205043 | NRIF signals cell death from the nucleus | 0.052269 | 1.282 |
R-HSA-193648 | NRAGE signals death through JNK | 0.015785 | 1.802 |
R-HSA-2122948 | Activated NOTCH1 Transmits Signal to the Nucleus | 0.091064 | 1.041 |
R-HSA-9820960 | Respiratory syncytial virus (RSV) attachment and entry | 0.104539 | 0.981 |
R-HSA-5602358 | Diseases associated with the TLR signaling cascade | 0.130905 | 0.883 |
R-HSA-5260271 | Diseases of Immune System | 0.130905 | 0.883 |
R-HSA-9711097 | Cellular response to starvation | 0.096942 | 1.013 |
R-HSA-8868773 | rRNA processing in the nucleus and cytosol | 0.003386 | 2.470 |
R-HSA-373760 | L1CAM interactions | 0.057576 | 1.240 |
R-HSA-8849932 | Synaptic adhesion-like molecules | 0.066307 | 1.178 |
R-HSA-168255 | Influenza Infection | 0.021316 | 1.671 |
R-HSA-416476 | G alpha (q) signalling events | 0.052762 | 1.278 |
R-HSA-399721 | Glutamate binding, activation of AMPA receptors and synaptic plasticity | 0.109874 | 0.959 |
R-HSA-9013694 | Signaling by NOTCH4 | 0.025052 | 1.601 |
R-HSA-9010553 | Regulation of expression of SLITs and ROBOs | 0.091448 | 1.039 |
R-HSA-445144 | Signal transduction by L1 | 0.071865 | 1.143 |
R-HSA-1980145 | Signaling by NOTCH2 | 0.115178 | 0.939 |
R-HSA-72312 | rRNA processing | 0.006748 | 2.171 |
R-HSA-9664424 | Cell recruitment (pro-inflammatory response) | 0.148907 | 0.827 |
R-HSA-9660826 | Purinergic signaling in leishmaniasis infection | 0.148907 | 0.827 |
R-HSA-9634638 | Estrogen-dependent nuclear events downstream of ESR-membrane signaling | 0.082884 | 1.082 |
R-HSA-435354 | Zinc transporters | 0.052269 | 1.282 |
R-HSA-749476 | RNA Polymerase III Abortive And Retractive Initiation | 0.120451 | 0.919 |
R-HSA-3928662 | EPHB-mediated forward signaling | 0.143801 | 0.842 |
R-HSA-9733709 | Cardiogenesis | 0.109874 | 0.959 |
R-HSA-157118 | Signaling by NOTCH | 0.042512 | 1.371 |
R-HSA-416482 | G alpha (12/13) signalling events | 0.027350 | 1.563 |
R-HSA-8939211 | ESR-mediated signaling | 0.041310 | 1.384 |
R-HSA-9018519 | Estrogen-dependent gene expression | 0.076429 | 1.117 |
R-HSA-2408522 | Selenoamino acid metabolism | 0.102529 | 0.989 |
R-HSA-193704 | p75 NTR receptor-mediated signalling | 0.004383 | 2.358 |
R-HSA-844456 | The NLRP3 inflammasome | 0.069090 | 1.161 |
R-HSA-2682334 | EPH-Ephrin signaling | 0.037340 | 1.428 |
R-HSA-8864260 | Transcriptional regulation by the AP-2 (TFAP2) family of transcription factors | 0.010659 | 1.972 |
R-HSA-3214841 | PKMTs methylate histone lysines | 0.133500 | 0.875 |
R-HSA-9839373 | Signaling by TGFBR3 | 0.148907 | 0.827 |
R-HSA-1169410 | Antiviral mechanism by IFN-stimulated genes | 0.014741 | 1.831 |
R-HSA-9700206 | Signaling by ALK in cancer | 0.049240 | 1.308 |
R-HSA-74158 | RNA Polymerase III Transcription | 0.120451 | 0.919 |
R-HSA-1650814 | Collagen biosynthesis and modifying enzymes | 0.021764 | 1.662 |
R-HSA-1236394 | Signaling by ERBB4 | 0.025052 | 1.601 |
R-HSA-9006931 | Signaling by Nuclear Receptors | 0.105937 | 0.975 |
R-HSA-622312 | Inflammasomes | 0.096478 | 1.016 |
R-HSA-376176 | Signaling by ROBO receptors | 0.141808 | 0.848 |
R-HSA-9725370 | Signaling by ALK fusions and activated point mutants | 0.049240 | 1.308 |
R-HSA-1251985 | Nuclear signaling by ERBB4 | 0.130905 | 0.883 |
R-HSA-1266738 | Developmental Biology | 0.062018 | 1.207 |
R-HSA-1474290 | Collagen formation | 0.038674 | 1.413 |
R-HSA-73887 | Death Receptor Signaling | 0.014741 | 1.831 |
R-HSA-913531 | Interferon Signaling | 0.119208 | 0.924 |
R-HSA-2262752 | Cellular responses to stress | 0.087146 | 1.060 |
R-HSA-381038 | XBP1(S) activates chaperone genes | 0.032817 | 1.484 |
R-HSA-8953897 | Cellular responses to stimuli | 0.131536 | 0.881 |
R-HSA-381070 | IRE1alpha activates chaperones | 0.036680 | 1.436 |
R-HSA-381119 | Unfolded Protein Response (UPR) | 0.079017 | 1.102 |
R-HSA-72766 | Translation | 0.150285 | 0.823 |
R-HSA-445989 | TAK1-dependent IKK and NF-kappa-B activation | 0.151449 | 0.820 |
R-HSA-3928665 | EPH-ephrin mediated repulsion of cells | 0.151449 | 0.820 |
R-HSA-5693571 | Nonhomologous End-Joining (NHEJ) | 0.153983 | 0.813 |
R-HSA-425410 | Metal ion SLC transporters | 0.153983 | 0.813 |
R-HSA-68882 | Mitotic Anaphase | 0.156239 | 0.806 |
R-HSA-2555396 | Mitotic Metaphase and Anaphase | 0.157280 | 0.803 |
R-HSA-112382 | Formation of RNA Pol II elongation complex | 0.164047 | 0.785 |
R-HSA-6794361 | Neurexins and neuroligins | 0.164047 | 0.785 |
R-HSA-1221632 | Meiotic synapsis | 0.166544 | 0.778 |
R-HSA-75955 | RNA Polymerase II Transcription Elongation | 0.166544 | 0.778 |
R-HSA-72649 | Translation initiation complex formation | 0.169034 | 0.772 |
R-HSA-72702 | Ribosomal scanning and start codon recognition | 0.173993 | 0.759 |
R-HSA-177929 | Signaling by EGFR | 0.173993 | 0.759 |
R-HSA-9662361 | Sensory processing of sound by outer hair cells of the cochlea | 0.173993 | 0.759 |
R-HSA-3247509 | Chromatin modifying enzymes | 0.175188 | 0.756 |
R-HSA-2980766 | Nuclear Envelope Breakdown | 0.176461 | 0.753 |
R-HSA-72662 | Activation of the mRNA upon binding of the cap-binding complex and eIFs, and sub... | 0.178923 | 0.747 |
R-HSA-201722 | Formation of the beta-catenin:TCF transactivating complex | 0.178923 | 0.747 |
R-HSA-5693565 | Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at... | 0.181376 | 0.741 |
R-HSA-429914 | Deadenylation-dependent mRNA decay | 0.181376 | 0.741 |
R-HSA-194441 | Metabolism of non-coding RNA | 0.181376 | 0.741 |
R-HSA-191859 | snRNP Assembly | 0.181376 | 0.741 |
R-HSA-1227986 | Signaling by ERBB2 | 0.183823 | 0.736 |
R-HSA-983189 | Kinesins | 0.183823 | 0.736 |
R-HSA-1660661 | Sphingolipid de novo biosynthesis | 0.183823 | 0.736 |
R-HSA-2644606 | Constitutive Signaling by NOTCH1 PEST Domain Mutants | 0.183823 | 0.736 |
R-HSA-2644602 | Signaling by NOTCH1 PEST Domain Mutants in Cancer | 0.183823 | 0.736 |
R-HSA-2894862 | Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants | 0.183823 | 0.736 |
R-HSA-2894858 | Signaling by NOTCH1 HD+PEST Domain Mutants in Cancer | 0.183823 | 0.736 |
R-HSA-2644603 | Signaling by NOTCH1 in Cancer | 0.183823 | 0.736 |
R-HSA-168325 | Viral Messenger RNA Synthesis | 0.186263 | 0.730 |
R-HSA-2559586 | DNA Damage/Telomere Stress Induced Senescence | 0.188695 | 0.724 |
R-HSA-6784531 | tRNA processing in the nucleus | 0.188695 | 0.724 |
R-HSA-8848021 | Signaling by PTK6 | 0.191121 | 0.719 |
R-HSA-9006927 | Signaling by Non-Receptor Tyrosine Kinases | 0.191121 | 0.719 |
R-HSA-4839726 | Chromatin organization | 0.191255 | 0.718 |
R-HSA-9609646 | HCMV Infection | 0.192334 | 0.716 |
R-HSA-168643 | Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signali... | 0.193539 | 0.713 |
R-HSA-9909649 | Regulation of PD-L1(CD274) transcription | 0.198354 | 0.703 |
R-HSA-5693606 | DNA Double Strand Break Response | 0.200751 | 0.697 |
R-HSA-5685942 | HDR through Homologous Recombination (HRR) | 0.200751 | 0.697 |
R-HSA-69620 | Cell Cycle Checkpoints | 0.200994 | 0.697 |
R-HSA-9662360 | Sensory processing of sound by inner hair cells of the cochlea | 0.203141 | 0.692 |
R-HSA-9734767 | Developmental Cell Lineages | 0.206431 | 0.685 |
R-HSA-1834949 | Cytosolic sensors of pathogen-associated DNA | 0.207900 | 0.682 |
R-HSA-5578749 | Transcriptional regulation by small RNAs | 0.212632 | 0.672 |
R-HSA-159236 | Transport of Mature mRNA derived from an Intron-Containing Transcript | 0.214987 | 0.668 |
R-HSA-674695 | RNA Polymerase II Pre-transcription Events | 0.217335 | 0.663 |
R-HSA-69473 | G2/M DNA damage checkpoint | 0.217335 | 0.663 |
R-HSA-1980143 | Signaling by NOTCH1 | 0.222011 | 0.654 |
R-HSA-72203 | Processing of Capped Intron-Containing Pre-mRNA | 0.223936 | 0.650 |
R-HSA-9658195 | Leishmania infection | 0.226134 | 0.646 |
R-HSA-9824443 | Parasitic Infection Pathways | 0.226134 | 0.646 |
R-HSA-4086400 | PCP/CE pathway | 0.226660 | 0.645 |
R-HSA-9659379 | Sensory processing of sound | 0.228974 | 0.640 |
R-HSA-5693607 | Processing of DNA double-strand break ends | 0.233582 | 0.632 |
R-HSA-72202 | Transport of Mature Transcript to Cytoplasm | 0.235876 | 0.627 |
R-HSA-5668541 | TNFR2 non-canonical NF-kB pathway | 0.238163 | 0.623 |
R-HSA-1500620 | Meiosis | 0.242718 | 0.615 |
R-HSA-5687128 | MAPK6/MAPK4 signaling | 0.242718 | 0.615 |
R-HSA-195721 | Signaling by WNT | 0.244878 | 0.611 |
R-HSA-141444 | Amplification of signal from unattached kinetochores via a MAD2 inhibitory si... | 0.244985 | 0.611 |
R-HSA-141424 | Amplification of signal from the kinetochores | 0.244985 | 0.611 |
R-HSA-6804756 | Regulation of TP53 Activity through Phosphorylation | 0.247245 | 0.607 |
R-HSA-5620912 | Anchoring of the basal body to the plasma membrane | 0.256221 | 0.591 |
R-HSA-74752 | Signaling by Insulin receptor | 0.262884 | 0.580 |
R-HSA-2219530 | Constitutive Signaling by Aberrant PI3K in Cancer | 0.267293 | 0.573 |
R-HSA-168928 | DDX58/IFIH1-mediated induction of interferon-alpha/beta | 0.269488 | 0.569 |
R-HSA-6811434 | COPI-dependent Golgi-to-ER retrograde traffic | 0.273859 | 0.562 |
R-HSA-5607764 | CLEC7A (Dectin-1) signaling | 0.273859 | 0.562 |
R-HSA-8957275 | Post-translational protein phosphorylation | 0.278204 | 0.556 |
R-HSA-975871 | MyD88 cascade initiated on plasma membrane | 0.278204 | 0.556 |
R-HSA-168142 | Toll Like Receptor 10 (TLR10) Cascade | 0.278204 | 0.556 |
R-HSA-168176 | Toll Like Receptor 5 (TLR5) Cascade | 0.278204 | 0.556 |
R-HSA-3214847 | HATs acetylate histones | 0.280367 | 0.552 |
R-HSA-1474244 | Extracellular matrix organization | 0.281429 | 0.551 |
R-HSA-69618 | Mitotic Spindle Checkpoint | 0.282524 | 0.549 |
R-HSA-70171 | Glycolysis | 0.282524 | 0.549 |
R-HSA-9009391 | Extra-nuclear estrogen signaling | 0.284674 | 0.546 |
R-HSA-9020702 | Interleukin-1 signaling | 0.284674 | 0.546 |
R-HSA-3371453 | Regulation of HSF1-mediated heat shock response | 0.286818 | 0.542 |
R-HSA-8856825 | Cargo recognition for clathrin-mediated endocytosis | 0.291087 | 0.536 |
R-HSA-162582 | Signal Transduction | 0.292036 | 0.535 |
R-HSA-9006934 | Signaling by Receptor Tyrosine Kinases | 0.292894 | 0.533 |
R-HSA-168164 | Toll Like Receptor 3 (TLR3) Cascade | 0.295332 | 0.530 |
R-HSA-5683057 | MAPK family signaling cascades | 0.299142 | 0.524 |
R-HSA-211000 | Gene Silencing by RNA | 0.299551 | 0.524 |
R-HSA-975138 | TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation | 0.301651 | 0.520 |
R-HSA-9648025 | EML4 and NUDC in mitotic spindle formation | 0.303746 | 0.517 |
R-HSA-975155 | MyD88 dependent cascade initiated on endosome | 0.303746 | 0.517 |
R-HSA-937061 | TRIF (TICAM1)-mediated TLR4 signaling | 0.305834 | 0.515 |
R-HSA-166166 | MyD88-independent TLR4 cascade | 0.305834 | 0.515 |
R-HSA-1483249 | Inositol phosphate metabolism | 0.309991 | 0.509 |
R-HSA-168181 | Toll Like Receptor 7/8 (TLR7/8) Cascade | 0.312061 | 0.506 |
R-HSA-5693567 | HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA) | 0.314125 | 0.503 |
R-HSA-381426 | Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-l... | 0.316182 | 0.500 |
R-HSA-168138 | Toll Like Receptor 9 (TLR9) Cascade | 0.318234 | 0.497 |
R-HSA-70326 | Glucose metabolism | 0.324352 | 0.489 |
R-HSA-5693538 | Homology Directed Repair | 0.326380 | 0.486 |
R-HSA-2219528 | PI3K/AKT Signaling in Cancer | 0.326380 | 0.486 |
R-HSA-166058 | MyD88:MAL(TIRAP) cascade initiated on plasma membrane | 0.328401 | 0.484 |
R-HSA-168188 | Toll Like Receptor TLR6:TLR2 Cascade | 0.328401 | 0.484 |
R-HSA-68875 | Mitotic Prophase | 0.330417 | 0.481 |
R-HSA-3371556 | Cellular response to heat stress | 0.332426 | 0.478 |
R-HSA-168179 | Toll Like Receptor TLR1:TLR2 Cascade | 0.334430 | 0.476 |
R-HSA-181438 | Toll Like Receptor 2 (TLR2) Cascade | 0.334430 | 0.476 |
R-HSA-6811558 | PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling | 0.336428 | 0.473 |
R-HSA-9816359 | Maternal to zygotic transition (MZT) | 0.336428 | 0.473 |
R-HSA-2132295 | MHC class II antigen presentation | 0.336428 | 0.473 |
R-HSA-162909 | Host Interactions of HIV factors | 0.338420 | 0.471 |
R-HSA-68886 | M Phase | 0.338741 | 0.470 |
R-HSA-69481 | G2/M Checkpoints | 0.346330 | 0.461 |
R-HSA-199418 | Negative regulation of the PI3K/AKT network | 0.352201 | 0.453 |
R-HSA-1474165 | Reproduction | 0.354147 | 0.451 |
R-HSA-8856688 | Golgi-to-ER retrograde transport | 0.358021 | 0.446 |
R-HSA-3858494 | Beta-catenin independent WNT signaling | 0.367607 | 0.435 |
R-HSA-9820952 | Respiratory Syncytial Virus Infection Pathway | 0.369507 | 0.432 |
R-HSA-1640170 | Cell Cycle | 0.371086 | 0.431 |
R-HSA-9705671 | SARS-CoV-2 activates/modulates innate and adaptive immune responses | 0.380793 | 0.419 |
R-HSA-162599 | Late Phase of HIV Life Cycle | 0.380793 | 0.419 |
R-HSA-8856828 | Clathrin-mediated endocytosis | 0.382654 | 0.417 |
R-HSA-69242 | S Phase | 0.391880 | 0.407 |
R-HSA-166016 | Toll Like Receptor 4 (TLR4) Cascade | 0.391880 | 0.407 |
R-HSA-446652 | Interleukin-1 family signaling | 0.399163 | 0.399 |
R-HSA-5693532 | DNA Double-Strand Break Repair | 0.400970 | 0.397 |
R-HSA-5663205 | Infectious disease | 0.402997 | 0.395 |
R-HSA-9610379 | HCMV Late Events | 0.408147 | 0.389 |
R-HSA-162587 | HIV Life Cycle | 0.408147 | 0.389 |
R-HSA-5633007 | Regulation of TP53 Activity | 0.413474 | 0.384 |
R-HSA-9006936 | Signaling by TGFB family members | 0.413474 | 0.384 |
R-HSA-1280215 | Cytokine Signaling in Immune system | 0.413705 | 0.383 |
R-HSA-388396 | GPCR downstream signalling | 0.424805 | 0.372 |
R-HSA-5619102 | SLC transporter disorders | 0.425722 | 0.371 |
R-HSA-112316 | Neuronal System | 0.430280 | 0.366 |
R-HSA-72306 | tRNA processing | 0.432608 | 0.364 |
R-HSA-5621481 | C-type lectin receptors (CLRs) | 0.434317 | 0.362 |
R-HSA-9909648 | Regulation of PD-L1(CD274) expression | 0.436021 | 0.360 |
R-HSA-983231 | Factors involved in megakaryocyte development and platelet production | 0.441102 | 0.355 |
R-HSA-2559583 | Cellular Senescence | 0.449472 | 0.347 |
R-HSA-9824446 | Viral Infection Pathways | 0.449813 | 0.347 |
R-HSA-5617833 | Cilium Assembly | 0.465844 | 0.332 |
R-HSA-168898 | Toll-like Receptor Cascades | 0.467455 | 0.330 |
R-HSA-72163 | mRNA Splicing - Major Pathway | 0.472259 | 0.326 |
R-HSA-6811442 | Intra-Golgi and retrograde Golgi-to-ER traffic | 0.481740 | 0.317 |
R-HSA-389948 | Co-inhibition by PD-1 | 0.481740 | 0.317 |
R-HSA-428157 | Sphingolipid metabolism | 0.483303 | 0.316 |
R-HSA-1643685 | Disease | 0.484607 | 0.315 |
R-HSA-72172 | mRNA Splicing | 0.489513 | 0.310 |
R-HSA-372790 | Signaling by GPCR | 0.490191 | 0.310 |
R-HSA-112314 | Neurotransmitter receptors and postsynaptic signal transmission | 0.501713 | 0.300 |
R-HSA-162906 | HIV Infection | 0.523823 | 0.281 |
R-HSA-9705683 | SARS-CoV-2-host interactions | 0.525262 | 0.280 |
R-HSA-69278 | Cell Cycle, Mitotic | 0.526276 | 0.279 |
R-HSA-5619115 | Disorders of transmembrane transporters | 0.551815 | 0.258 |
R-HSA-74160 | Gene expression (Transcription) | 0.553358 | 0.257 |
R-HSA-388841 | Regulation of T cell activation by CD28 family | 0.563879 | 0.249 |
R-HSA-71291 | Metabolism of amino acids and derivatives | 0.572791 | 0.242 |
R-HSA-199991 | Membrane Trafficking | 0.598138 | 0.223 |
R-HSA-392499 | Metabolism of proteins | 0.600648 | 0.221 |
R-HSA-5673001 | RAF/MAP kinase cascade | 0.605455 | 0.218 |
R-HSA-1257604 | PIP3 activates AKT signaling | 0.612586 | 0.213 |
R-HSA-5684996 | MAPK1/MAPK3 signaling | 0.613762 | 0.212 |
R-HSA-1852241 | Organelle biogenesis and maintenance | 0.640962 | 0.193 |
R-HSA-112315 | Transmission across Chemical Synapses | 0.644228 | 0.191 |
R-HSA-9006925 | Intracellular signaling by second messengers | 0.664243 | 0.178 |
R-HSA-9694516 | SARS-CoV-2 Infection | 0.671335 | 0.173 |
R-HSA-73894 | DNA Repair | 0.682185 | 0.166 |
R-HSA-5653656 | Vesicle-mediated transport | 0.714807 | 0.146 |
R-HSA-425407 | SLC-mediated transmembrane transport | 0.717036 | 0.144 |
R-HSA-597592 | Post-translational protein modification | 0.751475 | 0.124 |
R-HSA-71387 | Metabolism of carbohydrates and carbohydrate derivatives | 0.763134 | 0.117 |
R-HSA-73857 | RNA Polymerase II Transcription | 0.766211 | 0.116 |
R-HSA-3700989 | Transcriptional Regulation by TP53 | 0.770301 | 0.113 |
R-HSA-9679506 | SARS-CoV Infections | 0.825949 | 0.083 |
R-HSA-1280218 | Adaptive Immune System | 0.835982 | 0.078 |
R-HSA-449147 | Signaling by Interleukins | 0.859885 | 0.066 |
R-HSA-212436 | Generic Transcription Pathway | 0.860236 | 0.065 |
R-HSA-109582 | Hemostasis | 0.914702 | 0.039 |
R-HSA-168256 | Immune System | 0.936084 | 0.029 |
R-HSA-382551 | Transport of small molecules | 0.954212 | 0.020 |
R-HSA-9709957 | Sensory Perception | 0.979848 | 0.009 |
R-HSA-168249 | Innate Immune System | 0.985047 | 0.007 |
R-HSA-556833 | Metabolism of lipids | 0.991111 | 0.004 |
R-HSA-1430728 | Metabolism | 0.998277 | 0.001 |
Download
kinase | JSD_mean | pearson_surrounding | kinase_max_IC_position | max_position_JSD |
---|---|---|---|---|
BMPR1B |
0.668 | 0.320 | 1 | 0.594 |
CK2A2 |
0.666 | 0.312 | 1 | 0.688 |
BMPR1A |
0.665 | 0.336 | 1 | 0.583 |
FAM20C |
0.663 | 0.088 | 2 | 0.321 |
TGFBR1 |
0.663 | 0.370 | -2 | 0.759 |
COT |
0.660 | 0.102 | 2 | 0.377 |
GRK4 |
0.659 | 0.161 | -2 | 0.561 |
ALK2 |
0.658 | 0.380 | -2 | 0.742 |
CK2A1 |
0.658 | 0.281 | 1 | 0.677 |
CAMK2G |
0.657 | 0.260 | 2 | 0.562 |
GRK1 |
0.656 | 0.120 | -2 | 0.489 |
MOS |
0.655 | 0.199 | 1 | 0.707 |
GRK6 |
0.655 | 0.169 | 1 | 0.625 |
ACVR2A |
0.654 | 0.281 | -2 | 0.693 |
ACVR2B |
0.654 | 0.289 | -2 | 0.690 |
CAMK2B |
0.653 | 0.220 | 2 | 0.569 |
KIS |
0.651 | 0.064 | 1 | 0.544 |
ALK4 |
0.651 | 0.327 | -2 | 0.741 |
CDC7 |
0.649 | 0.056 | 1 | 0.677 |
GRK7 |
0.648 | 0.113 | 1 | 0.558 |
GRK3 |
0.647 | 0.100 | -2 | 0.525 |
NDR2 |
0.647 | 0.075 | -3 | 0.587 |
TGFBR2 |
0.647 | 0.172 | -2 | 0.718 |
CK1E |
0.647 | 0.122 | -3 | 0.739 |
IKKB |
0.647 | 0.006 | -2 | 0.411 |
DSTYK |
0.645 | 0.100 | 2 | 0.404 |
CLK3 |
0.645 | 0.083 | 1 | 0.597 |
PLK2 |
0.645 | 0.160 | -3 | 0.682 |
IKKA |
0.645 | 0.039 | -2 | 0.442 |
PLK3 |
0.644 | 0.136 | 2 | 0.440 |
GRK5 |
0.644 | 0.068 | -3 | 0.685 |
GCN2 |
0.644 | 0.050 | 2 | 0.426 |
CAMK2A |
0.644 | 0.222 | 2 | 0.603 |
CK1D |
0.644 | 0.148 | -3 | 0.710 |
PLK1 |
0.644 | 0.110 | -2 | 0.601 |
ATM |
0.642 | 0.105 | 1 | 0.550 |
IKKE |
0.641 | -0.013 | 1 | 0.603 |
GRK2 |
0.641 | 0.074 | -2 | 0.522 |
BCKDK |
0.640 | 0.008 | -1 | 0.500 |
BMPR2 |
0.640 | 0.180 | -2 | 0.586 |
TBK1 |
0.640 | -0.031 | 1 | 0.601 |
PRPK |
0.640 | -0.027 | -1 | 0.465 |
TLK2 |
0.639 | 0.143 | 1 | 0.614 |
CK1A2 |
0.639 | 0.129 | -3 | 0.715 |
TLK1 |
0.638 | 0.247 | -2 | 0.659 |
CK1G1 |
0.638 | 0.093 | -3 | 0.715 |
PDHK4 |
0.636 | -0.048 | 1 | 0.678 |
MTOR |
0.636 | -0.082 | 1 | 0.648 |
PDHK1 |
0.635 | 0.001 | 1 | 0.672 |
LATS2 |
0.635 | 0.096 | -5 | 0.539 |
RAF1 |
0.635 | -0.021 | 1 | 0.651 |
NEK6 |
0.634 | 0.025 | -2 | 0.611 |
NEK7 |
0.634 | -0.009 | -3 | 0.598 |
CAMK1B |
0.632 | -0.020 | -3 | 0.617 |
ATR |
0.631 | -0.032 | 1 | 0.614 |
PIM3 |
0.630 | -0.042 | -3 | 0.594 |
CAMK2D |
0.630 | 0.100 | -3 | 0.557 |
ULK2 |
0.628 | -0.126 | 2 | 0.349 |
TTBK2 |
0.628 | -0.097 | 2 | 0.305 |
PRKX |
0.627 | 0.045 | -3 | 0.494 |
RSK2 |
0.627 | -0.022 | -3 | 0.516 |
DNAPK |
0.626 | 0.094 | 1 | 0.544 |
ULK1 |
0.626 | -0.097 | -3 | 0.608 |
ANKRD3 |
0.626 | 0.048 | 1 | 0.633 |
MLK1 |
0.625 | -0.084 | 2 | 0.334 |
NDR1 |
0.625 | -0.039 | -3 | 0.581 |
DLK |
0.625 | -0.029 | 1 | 0.651 |
AURA |
0.625 | -0.012 | -2 | 0.313 |
PKN3 |
0.623 | -0.051 | -3 | 0.580 |
ERK5 |
0.623 | -0.071 | 1 | 0.616 |
SRPK1 |
0.623 | -0.006 | -3 | 0.509 |
NLK |
0.622 | -0.102 | 1 | 0.644 |
CK1A |
0.622 | 0.107 | -3 | 0.673 |
LATS1 |
0.622 | 0.079 | -3 | 0.572 |
SKMLCK |
0.621 | -0.077 | -2 | 0.462 |
CDKL1 |
0.621 | -0.052 | -3 | 0.547 |
PIM1 |
0.621 | -0.002 | -3 | 0.577 |
MST4 |
0.621 | -0.076 | 2 | 0.348 |
SRPK3 |
0.621 | 0.005 | -3 | 0.505 |
MEKK3 |
0.620 | 0.010 | 1 | 0.626 |
MLK4 |
0.620 | -0.027 | 2 | 0.304 |
P90RSK |
0.620 | -0.051 | -3 | 0.522 |
CDK1 |
0.620 | 0.024 | 1 | 0.493 |
MSK1 |
0.620 | 0.004 | -3 | 0.492 |
MAPKAPK2 |
0.619 | 0.021 | -3 | 0.481 |
PRKD1 |
0.619 | -0.038 | -3 | 0.516 |
MEK1 |
0.619 | 0.001 | 2 | 0.414 |
RSK4 |
0.619 | -0.022 | -3 | 0.514 |
SRPK2 |
0.618 | 0.002 | -3 | 0.455 |
HUNK |
0.618 | -0.137 | 2 | 0.373 |
DAPK2 |
0.618 | -0.063 | -3 | 0.605 |
PLK4 |
0.618 | -0.086 | 2 | 0.324 |
PKACG |
0.618 | -0.061 | -2 | 0.392 |
CDK8 |
0.618 | -0.022 | 1 | 0.537 |
NUAK2 |
0.617 | -0.075 | -3 | 0.620 |
MSK2 |
0.617 | -0.023 | -3 | 0.491 |
MASTL |
0.617 | -0.168 | -2 | 0.453 |
NIK |
0.617 | -0.126 | -3 | 0.636 |
MARK4 |
0.617 | -0.084 | 4 | 0.705 |
CDKL5 |
0.616 | -0.052 | -3 | 0.526 |
PKACB |
0.616 | -0.012 | -2 | 0.343 |
YSK4 |
0.616 | -0.027 | 1 | 0.627 |
RIPK3 |
0.616 | -0.147 | 3 | 0.619 |
CLK2 |
0.616 | 0.022 | -3 | 0.545 |
ICK |
0.616 | -0.045 | -3 | 0.570 |
CAMLCK |
0.615 | -0.086 | -2 | 0.451 |
TSSK2 |
0.615 | -0.061 | -5 | 0.648 |
PASK |
0.614 | 0.067 | -3 | 0.609 |
P70S6KB |
0.614 | -0.055 | -3 | 0.554 |
CHAK2 |
0.614 | -0.138 | -1 | 0.423 |
PRKD2 |
0.614 | -0.040 | -3 | 0.511 |
PKN2 |
0.614 | -0.101 | -3 | 0.600 |
RSK3 |
0.614 | -0.071 | -3 | 0.507 |
HIPK4 |
0.613 | -0.073 | 1 | 0.607 |
AMPKA1 |
0.613 | -0.087 | -3 | 0.606 |
CK1G2 |
0.612 | 0.131 | -3 | 0.691 |
BRAF |
0.612 | 0.100 | -4 | 0.658 |
WNK1 |
0.612 | -0.117 | -2 | 0.456 |
CLK4 |
0.612 | -0.017 | -3 | 0.562 |
NEK9 |
0.612 | -0.154 | 2 | 0.352 |
JNK3 |
0.612 | 0.002 | 1 | 0.524 |
AURC |
0.612 | -0.059 | -2 | 0.328 |
CK1G3 |
0.612 | 0.128 | -3 | 0.649 |
WNK3 |
0.611 | -0.204 | 1 | 0.616 |
PKCD |
0.611 | -0.098 | 2 | 0.332 |
MLK3 |
0.610 | -0.091 | 2 | 0.295 |
CHK1 |
0.610 | 0.017 | -3 | 0.557 |
ZAK |
0.610 | -0.028 | 1 | 0.633 |
CAMK4 |
0.610 | -0.090 | -3 | 0.597 |
GSK3A |
0.609 | 0.030 | 4 | 0.375 |
BRSK1 |
0.609 | -0.052 | -3 | 0.541 |
PTK2 |
0.609 | 0.198 | -1 | 0.646 |
TSSK1 |
0.609 | -0.084 | -3 | 0.612 |
P38B |
0.608 | 0.001 | 1 | 0.504 |
MEKK2 |
0.608 | -0.044 | 2 | 0.355 |
P38G |
0.607 | -0.004 | 1 | 0.434 |
SMG1 |
0.607 | -0.074 | 1 | 0.575 |
CDK19 |
0.607 | -0.038 | 1 | 0.502 |
TTBK1 |
0.607 | -0.103 | 2 | 0.275 |
DYRK2 |
0.607 | -0.038 | 1 | 0.546 |
JNK2 |
0.607 | -0.007 | 1 | 0.500 |
RIPK1 |
0.606 | -0.200 | 1 | 0.581 |
MEKK1 |
0.605 | -0.036 | 1 | 0.623 |
PDHK1_TYR |
0.604 | 0.239 | -1 | 0.531 |
PERK |
0.604 | -0.023 | -2 | 0.612 |
HRI |
0.604 | -0.019 | -2 | 0.596 |
MAP2K6_TYR |
0.604 | 0.242 | -1 | 0.521 |
IRE1 |
0.604 | -0.164 | 1 | 0.554 |
AMPKA2 |
0.604 | -0.090 | -3 | 0.576 |
PRP4 |
0.604 | -0.021 | -3 | 0.569 |
P38A |
0.604 | -0.030 | 1 | 0.546 |
AURB |
0.603 | -0.072 | -2 | 0.324 |
VRK2 |
0.603 | -0.225 | 1 | 0.655 |
PKR |
0.603 | -0.104 | 1 | 0.600 |
PAK1 |
0.603 | -0.113 | -2 | 0.363 |
DRAK1 |
0.603 | -0.092 | 1 | 0.567 |
YANK3 |
0.603 | -0.002 | 2 | 0.189 |
FLT1 |
0.603 | 0.234 | -1 | 0.627 |
MYLK4 |
0.603 | -0.072 | -2 | 0.370 |
MAPKAPK3 |
0.602 | -0.087 | -3 | 0.499 |
DCAMKL1 |
0.602 | -0.040 | -3 | 0.556 |
IRE2 |
0.602 | -0.105 | 2 | 0.295 |
PDHK3_TYR |
0.602 | 0.215 | 4 | 0.761 |
DYRK4 |
0.602 | -0.008 | 1 | 0.498 |
CLK1 |
0.602 | -0.039 | -3 | 0.525 |
PKACA |
0.601 | -0.031 | -2 | 0.308 |
P38D |
0.601 | 0.002 | 1 | 0.442 |
TAO3 |
0.601 | -0.042 | 1 | 0.627 |
BMPR2_TYR |
0.601 | 0.153 | -1 | 0.552 |
MLK2 |
0.601 | -0.195 | 2 | 0.351 |
NUAK1 |
0.601 | -0.091 | -3 | 0.555 |
PDHK4_TYR |
0.601 | 0.179 | 2 | 0.460 |
NIM1 |
0.601 | -0.175 | 3 | 0.615 |
MARK2 |
0.600 | -0.073 | 4 | 0.613 |
CDK13 |
0.600 | -0.043 | 1 | 0.507 |
PAK6 |
0.600 | -0.088 | -2 | 0.284 |
QSK |
0.600 | -0.088 | 4 | 0.679 |
PHKG1 |
0.600 | -0.105 | -3 | 0.583 |
ERK1 |
0.600 | -0.033 | 1 | 0.496 |
PKG2 |
0.600 | -0.085 | -2 | 0.344 |
PKCG |
0.599 | -0.133 | 2 | 0.281 |
DCAMKL2 |
0.599 | -0.052 | -3 | 0.574 |
MEK5 |
0.599 | -0.164 | 2 | 0.373 |
CDK5 |
0.598 | -0.036 | 1 | 0.526 |
CDK18 |
0.598 | -0.028 | 1 | 0.460 |
MAP2K4_TYR |
0.598 | 0.196 | -1 | 0.514 |
CDK17 |
0.598 | -0.019 | 1 | 0.430 |
CDK7 |
0.598 | -0.053 | 1 | 0.533 |
HIPK2 |
0.598 | -0.028 | 1 | 0.482 |
GSK3B |
0.598 | -0.013 | 4 | 0.373 |
JNK1 |
0.598 | 0.002 | 1 | 0.485 |
MARK3 |
0.598 | -0.078 | 4 | 0.644 |
PAK2 |
0.598 | -0.131 | -2 | 0.352 |
EPHA6 |
0.598 | 0.161 | -1 | 0.584 |
AKT2 |
0.598 | -0.057 | -3 | 0.478 |
SYK |
0.597 | 0.155 | -1 | 0.592 |
MNK1 |
0.597 | -0.110 | -2 | 0.404 |
PKCB |
0.597 | -0.128 | 2 | 0.278 |
MNK2 |
0.597 | -0.122 | -2 | 0.393 |
SIK |
0.596 | -0.083 | -3 | 0.533 |
PKCH |
0.596 | -0.141 | 2 | 0.277 |
TTK |
0.596 | 0.118 | -2 | 0.640 |
CDK2 |
0.596 | -0.039 | 1 | 0.545 |
ERK2 |
0.596 | -0.050 | 1 | 0.522 |
PAK3 |
0.596 | -0.157 | -2 | 0.346 |
BRSK2 |
0.596 | -0.112 | -3 | 0.553 |
CDK3 |
0.595 | -0.006 | 1 | 0.441 |
PRKD3 |
0.595 | -0.083 | -3 | 0.490 |
EGFR |
0.595 | 0.108 | 1 | 0.525 |
SSTK |
0.594 | -0.074 | 4 | 0.682 |
HIPK1 |
0.594 | -0.050 | 1 | 0.551 |
PKCA |
0.594 | -0.137 | 2 | 0.273 |
INSRR |
0.594 | 0.145 | 3 | 0.607 |
SGK3 |
0.594 | -0.096 | -3 | 0.501 |
MARK1 |
0.594 | -0.092 | 4 | 0.665 |
DAPK3 |
0.594 | -0.022 | -3 | 0.577 |
CAMK1G |
0.594 | -0.081 | -3 | 0.537 |
MST2 |
0.594 | 0.028 | 1 | 0.623 |
DAPK1 |
0.593 | -0.029 | -3 | 0.572 |
CDK12 |
0.593 | -0.049 | 1 | 0.491 |
EPHA4 |
0.593 | 0.130 | 2 | 0.426 |
EEF2K |
0.593 | -0.012 | 3 | 0.664 |
GAK |
0.593 | -0.043 | 1 | 0.578 |
MAPKAPK5 |
0.593 | -0.098 | -3 | 0.453 |
MST3 |
0.592 | -0.115 | 2 | 0.323 |
SNRK |
0.592 | -0.179 | 2 | 0.324 |
SMMLCK |
0.592 | -0.060 | -3 | 0.562 |
QIK |
0.592 | -0.172 | -3 | 0.575 |
FGFR3 |
0.592 | 0.125 | 3 | 0.650 |
FGFR2 |
0.592 | 0.119 | 3 | 0.668 |
EPHA5 |
0.591 | 0.172 | 2 | 0.432 |
NEK5 |
0.591 | -0.136 | 1 | 0.592 |
FGFR4 |
0.591 | 0.104 | -1 | 0.529 |
JAK3 |
0.590 | 0.134 | 1 | 0.628 |
TXK |
0.590 | 0.081 | 1 | 0.656 |
DYRK1A |
0.589 | -0.060 | 1 | 0.572 |
EPHB4 |
0.589 | 0.096 | -1 | 0.564 |
CHAK1 |
0.589 | -0.223 | 2 | 0.303 |
CAMK1D |
0.589 | -0.029 | -3 | 0.458 |
PINK1 |
0.589 | -0.131 | 1 | 0.618 |
NEK2 |
0.589 | -0.208 | 2 | 0.331 |
PAK4 |
0.589 | -0.091 | -2 | 0.266 |
EPHB2 |
0.589 | 0.131 | -1 | 0.565 |
NEK11 |
0.589 | -0.170 | 1 | 0.630 |
TAK1 |
0.588 | -0.006 | 1 | 0.653 |
EPHB1 |
0.588 | 0.111 | 1 | 0.632 |
MAP2K7_TYR |
0.588 | -0.048 | 2 | 0.438 |
PIM2 |
0.588 | -0.075 | -3 | 0.508 |
NEK8 |
0.587 | -0.126 | 2 | 0.336 |
PHKG2 |
0.587 | -0.118 | -3 | 0.576 |
MELK |
0.587 | -0.152 | -3 | 0.543 |
CDK16 |
0.587 | -0.023 | 1 | 0.437 |
EPHA3 |
0.586 | 0.111 | 2 | 0.418 |
KIT |
0.586 | 0.056 | 3 | 0.649 |
PKCZ |
0.586 | -0.181 | 2 | 0.300 |
WNK4 |
0.586 | -0.180 | -2 | 0.462 |
ERK7 |
0.586 | -0.068 | 2 | 0.190 |
FER |
0.586 | 0.033 | 1 | 0.631 |
TAO2 |
0.585 | -0.116 | 2 | 0.362 |
TESK1_TYR |
0.585 | -0.047 | 3 | 0.694 |
EPHA2 |
0.585 | 0.151 | -1 | 0.574 |
DYRK1B |
0.585 | -0.045 | 1 | 0.487 |
AKT1 |
0.585 | -0.068 | -3 | 0.483 |
GCK |
0.585 | -0.064 | 1 | 0.625 |
DYRK3 |
0.585 | -0.061 | 1 | 0.556 |
EPHB3 |
0.584 | 0.087 | -1 | 0.552 |
SRMS |
0.584 | 0.043 | 1 | 0.627 |
EPHA7 |
0.584 | 0.081 | 2 | 0.404 |
PDK1 |
0.584 | -0.120 | 1 | 0.592 |
EPHA8 |
0.584 | 0.086 | -1 | 0.533 |
ERBB4 |
0.584 | 0.092 | 1 | 0.524 |
PAK5 |
0.583 | -0.110 | -2 | 0.253 |
MET |
0.583 | 0.056 | 3 | 0.638 |
RET |
0.582 | -0.038 | 1 | 0.614 |
ERBB2 |
0.582 | 0.050 | 1 | 0.587 |
IRAK1 |
0.582 | -0.211 | -1 | 0.365 |
KDR |
0.582 | 0.053 | 3 | 0.609 |
FGFR1 |
0.582 | 0.059 | 3 | 0.640 |
FGR |
0.581 | -0.013 | 1 | 0.604 |
DDR1 |
0.581 | -0.024 | 4 | 0.745 |
P70S6K |
0.581 | -0.094 | -3 | 0.459 |
CDK9 |
0.581 | -0.083 | 1 | 0.506 |
AKT3 |
0.580 | -0.051 | -3 | 0.413 |
PINK1_TYR |
0.580 | -0.122 | 1 | 0.649 |
ALPHAK3 |
0.580 | 0.025 | -1 | 0.485 |
SBK |
0.580 | -0.003 | -3 | 0.374 |
CDK14 |
0.580 | -0.064 | 1 | 0.490 |
OSR1 |
0.580 | -0.000 | 2 | 0.336 |
FLT4 |
0.580 | 0.068 | 3 | 0.607 |
SGK1 |
0.580 | -0.053 | -3 | 0.403 |
CAMKK1 |
0.580 | -0.141 | -2 | 0.373 |
YANK2 |
0.579 | -0.001 | 2 | 0.197 |
HIPK3 |
0.579 | -0.086 | 1 | 0.552 |
CSF1R |
0.579 | -0.027 | 3 | 0.629 |
IRAK4 |
0.579 | -0.222 | 1 | 0.543 |
FYN |
0.578 | 0.011 | -1 | 0.470 |
PKCT |
0.578 | -0.157 | 2 | 0.284 |
NTRK1 |
0.578 | 0.040 | -1 | 0.545 |
IGF1R |
0.578 | 0.073 | 3 | 0.542 |
MST1R |
0.577 | -0.034 | 3 | 0.658 |
MAK |
0.577 | -0.029 | -2 | 0.391 |
CDK10 |
0.577 | -0.052 | 1 | 0.475 |
MPSK1 |
0.577 | -0.136 | 1 | 0.568 |
BLK |
0.577 | 0.027 | -1 | 0.475 |
MINK |
0.577 | -0.110 | 1 | 0.616 |
MST1 |
0.576 | -0.065 | 1 | 0.611 |
YES1 |
0.576 | -0.047 | -1 | 0.460 |
STK33 |
0.576 | -0.150 | 2 | 0.275 |
MAP3K15 |
0.576 | -0.179 | 1 | 0.621 |
INSR |
0.576 | 0.044 | 3 | 0.586 |
JAK2 |
0.575 | -0.060 | 1 | 0.617 |
DMPK1 |
0.575 | -0.018 | -3 | 0.548 |
NTRK3 |
0.575 | 0.030 | -1 | 0.517 |
TYK2 |
0.575 | -0.097 | 1 | 0.609 |
PKMYT1_TYR |
0.575 | -0.172 | 3 | 0.685 |
ZAP70 |
0.575 | 0.056 | -1 | 0.479 |
PDGFRB |
0.574 | -0.027 | 3 | 0.649 |
CAMKK2 |
0.574 | -0.125 | -2 | 0.361 |
PKCE |
0.574 | -0.118 | 2 | 0.263 |
TNIK |
0.574 | -0.104 | 3 | 0.647 |
RIPK2 |
0.574 | -0.166 | 1 | 0.606 |
HGK |
0.574 | -0.123 | 3 | 0.653 |
HPK1 |
0.574 | -0.114 | 1 | 0.613 |
MRCKA |
0.574 | -0.064 | -3 | 0.519 |
LKB1 |
0.573 | -0.152 | -3 | 0.580 |
FLT3 |
0.573 | -0.029 | 3 | 0.613 |
ABL2 |
0.573 | -0.038 | -1 | 0.459 |
MEK2 |
0.573 | -0.150 | 2 | 0.386 |
MRCKB |
0.573 | -0.079 | -3 | 0.509 |
HCK |
0.572 | -0.052 | -1 | 0.471 |
CSK |
0.572 | -0.017 | 2 | 0.408 |
LCK |
0.571 | -0.018 | -1 | 0.478 |
KHS2 |
0.571 | -0.079 | 1 | 0.618 |
SLK |
0.571 | -0.128 | -2 | 0.376 |
MERTK |
0.571 | -0.065 | 3 | 0.606 |
CHK2 |
0.571 | -0.072 | -3 | 0.431 |
NTRK2 |
0.570 | 0.017 | 3 | 0.621 |
LRRK2 |
0.570 | -0.202 | 2 | 0.371 |
ROS1 |
0.570 | -0.109 | 3 | 0.594 |
TYRO3 |
0.570 | -0.130 | 3 | 0.617 |
LTK |
0.570 | -0.028 | 3 | 0.625 |
PKG1 |
0.569 | -0.091 | -2 | 0.274 |
MATK |
0.569 | -0.025 | -1 | 0.414 |
DDR2 |
0.569 | 0.030 | 3 | 0.658 |
TEC |
0.569 | -0.039 | -1 | 0.380 |
ROCK2 |
0.569 | -0.085 | -3 | 0.547 |
PKCI |
0.568 | -0.168 | 2 | 0.279 |
LYN |
0.568 | -0.015 | 3 | 0.588 |
PKN1 |
0.568 | -0.114 | -3 | 0.477 |
KHS1 |
0.568 | -0.106 | 1 | 0.610 |
ITK |
0.568 | -0.072 | -1 | 0.442 |
CAMK1A |
0.568 | -0.062 | -3 | 0.439 |
VRK1 |
0.568 | -0.223 | 2 | 0.349 |
BMX |
0.568 | -0.054 | -1 | 0.385 |
NEK4 |
0.567 | -0.217 | 1 | 0.586 |
ABL1 |
0.567 | -0.066 | -1 | 0.450 |
PTK2B |
0.567 | -0.027 | -1 | 0.406 |
FRK |
0.567 | -0.039 | -1 | 0.468 |
ALK |
0.567 | -0.049 | 3 | 0.608 |
SRC |
0.565 | -0.036 | -1 | 0.462 |
CDK6 |
0.565 | -0.066 | 1 | 0.472 |
MEKK6 |
0.565 | -0.254 | 1 | 0.623 |
YSK1 |
0.565 | -0.161 | 2 | 0.324 |
LIMK1_TYR |
0.563 | -0.217 | 2 | 0.394 |
LOK |
0.563 | -0.184 | -2 | 0.376 |
PDGFRA |
0.563 | -0.097 | 3 | 0.636 |
TEK |
0.563 | -0.098 | 3 | 0.587 |
LIMK2_TYR |
0.563 | -0.203 | -3 | 0.599 |
CDK4 |
0.563 | -0.063 | 1 | 0.480 |
AXL |
0.562 | -0.121 | 3 | 0.635 |
EPHA1 |
0.562 | -0.050 | 3 | 0.619 |
BTK |
0.562 | -0.146 | -1 | 0.393 |
MOK |
0.562 | -0.071 | 1 | 0.540 |
PTK6 |
0.562 | -0.127 | -1 | 0.409 |
HASPIN |
0.561 | -0.094 | -1 | 0.290 |
STLK3 |
0.561 | -0.088 | 1 | 0.607 |
NEK1 |
0.560 | -0.222 | 1 | 0.572 |
ASK1 |
0.560 | -0.126 | 1 | 0.623 |
TNK2 |
0.560 | -0.101 | 3 | 0.665 |
NEK10_TYR |
0.559 | -0.130 | 1 | 0.564 |
JAK1 |
0.558 | -0.124 | 1 | 0.603 |
CRIK |
0.558 | -0.062 | -3 | 0.459 |
TNNI3K_TYR |
0.557 | -0.094 | 1 | 0.627 |
WEE1_TYR |
0.557 | -0.126 | -1 | 0.381 |
ROCK1 |
0.555 | -0.097 | -3 | 0.525 |
FES |
0.554 | -0.035 | -1 | 0.390 |
NEK3 |
0.554 | -0.197 | 1 | 0.584 |
TAO1 |
0.553 | -0.137 | 1 | 0.590 |
MYO3A |
0.549 | -0.139 | 1 | 0.587 |
PBK |
0.549 | -0.150 | 1 | 0.509 |
BIKE |
0.547 | -0.077 | 1 | 0.457 |
TNK1 |
0.544 | -0.229 | 3 | 0.585 |
MYO3B |
0.542 | -0.184 | 2 | 0.329 |
MUSK |
0.541 | -0.115 | 1 | 0.494 |
BUB1 |
0.534 | -0.167 | -5 | 0.541 |
AAK1 |
0.526 | -0.069 | 1 | 0.361 |